

 



<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
  "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml"
      xmlns:foaf="http://xmlns.com/foaf/0.1/"
      xmlns:dc="http://purl.org/dc/terms/"
      xmlns:doi="http://dx.doi.org/"
      xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
      xmlns:xsd="http://www.w3.org/2001/XMLSchema-datatypes#"
      lang="en" xml:lang="en"
      itemscope itemtype="http://schema.org/Article"
      class="no-js">
<head prefix="og: http://ogp.me/ns#">
  <title>PLOS ONE: Role of Transferrin Receptor and the ABC Transporters ABCB6 and ABCB7 for Resistance and Differentiation of Tumor Cells towards Artesunate</title>


<link rel="stylesheet" type="text/css"  href="/css/global-min.css?v=izteQ6tu7kgsJZW_xmrYizvKiHM" />


    <!--[if lte IE 7]>
<link rel="stylesheet" type="text/css"  href="/css/lte_ie7-min.css?v=3bykQUyQmReeuobVyPozcJ9LxRc" />
    <![endif]-->


<link rel="stylesheet" type="text/css"  href="/css/jquery-ui-min.css?v=eXDHTEJM0lIAmDe5k0I0Ad4nxNo" />


<link rel="stylesheet" type="text/css"  href="/css/journal.css?v=T7ZVxJfgk9jNxLAJ2qHz1vZpgYU" />


<link rel="stylesheet" type="text/css" media="print" href="/css/print-min.css?v=T5lb0B3q6EXBsuDluc5V5w+AkRc" />


  <link rel="stylesheet" href="http://f.fontdeck.com/s/css/js/www.plosone.org/24557.css" type="text/css"/>

  <!--chartbeat -->
  <script type="text/javascript">var _sf_startpt = (new Date()).getTime()</script>
  <script>document.documentElement.className += ' js';</script>

  <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
  <meta http-equiv="X-UA-Compatible" content="IE=EmulateIE7; IE=EmulateIE9"/>
  <meta name="description" content="PLOS ONE: an inclusive, peer-reviewed, open-access resource from the PUBLIC LIBRARY OF SCIENCE. Reports of well-performed scientific studies from all disciplines freely available to the whole world."/>
  <meta name="keywords" content="PLOS, Public Library of Science, Open Access, Open-Access, Science, Medicine, Biology, Research, Peer-review, Inclusive, Interdisciplinary, Ante-disciplinary, Physics, Chemistry, Engineering"/>
  <meta name="almHost" content="http://alm.plos.org/api/v3/articles"/>
  <meta name="searchHost" content="http://api.plos.org/search" />
  <meta name="termsHost" content="http://api.plos.org/terms" />
  <meta name="solrApiKey" content="plos"/>
  <meta name="almAPIKey" content="3pezRBRXdyzYW6ztfwft" />
  <meta name="currentJournal" content="PLoSONE" />
  <meta name="almRequestBatchSize" content="" />

  <meta name="citation_publisher" content="Public Library of Science"/>
  <meta name="citation_doi" content="10.1371/journal.pone.0000798"/>
  <meta name="dc.identifier" content="10.1371/journal.pone.0000798" />

    <meta name="citation_title" content="Role of Transferrin Receptor and the ABC Transporters ABCB6 and ABCB7 for Resistance and Differentiation of Tumor Cells towards Artesunate"/>
    <meta itemprop="name" content="Role of Transferrin Receptor and the ABC Transporters ABCB6 and ABCB7 for Resistance and Differentiation of Tumor Cells towards Artesunate"/>

      <meta name="citation_author" content="Gerhard Kelter"/>
            <meta name="citation_author_institution" content="Oncotest GmbH, Institute of Experimental Oncology, Freiburg, Germany"/>
      <meta name="citation_author" content="Daniel Steinbach"/>
            <meta name="citation_author_institution" content="Department for Pediatrics, University of Ulm, Ulm, Germany"/>
      <meta name="citation_author" content="Venkata Badireenath Konkimalla"/>
            <meta name="citation_author_institution" content="Pharmaceutical Biology (C015), German Cancer Research Center, Heidelberg, Germany"/>
      <meta name="citation_author" content="Tsuyoshi Tahara"/>
            <meta name="citation_author_institution" content="Department of Biotechnology, Kyoto Institute of Technology, Kyoto, Japan"/>
      <meta name="citation_author" content="Shigeru Taketani"/>
            <meta name="citation_author_institution" content="Department of Biotechnology, Kyoto Institute of Technology, Kyoto, Japan"/>
      <meta name="citation_author" content="Heinz-Herbert Fiebig"/>
            <meta name="citation_author_institution" content="Oncotest GmbH, Institute of Experimental Oncology, Freiburg, Germany"/>
      <meta name="citation_author" content="Thomas Efferth"/>
            <meta name="citation_author_institution" content="Pharmaceutical Biology (C015), German Cancer Research Center, Heidelberg, Germany"/>

    <meta name="citation_date" content="2007/8/29"/>

  <meta name="citation_pdf_url" content="http://dx.plos.org/10.1371/journal.pone.0000798.pdf" />

      <meta name="citation_journal_title" content="PLOS ONE" />
    <meta name="citation_firstpage" content="e798"/>
    <meta name="citation_issue" content="8"/>
    <meta name="citation_volume" content="2"/>
    <meta name="citation_issn" content="1932-6203"/>

    <meta name="citation_journal_abbrev" content="PLoS ONE" />

      <meta name="citation_reference" content="citation_title=Qinghaosu (artemisinin): an antimalarial drug from China.; citation_author=DL Klayman; citation_journal_title=Science; citation_volume=228; citation_number=1; citation_pages=1049-1055; citation_date=1985; " />
      <meta name="citation_reference" content="citation_title=Artemisinin-based combinations.; citation_author=EA Ashley; citation_author=NJ White; citation_journal_title=Curr Opin Infect Dis; citation_volume=18; citation_number=2; citation_pages=531-536; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Willmar Schwabe Award 2006: antiplasmodial and antitumor activity of artemisinin–from bench to bedside.; citation_author=T Efferth; citation_journal_title=Planta Med; citation_volume=73; citation_number=3; citation_pages=299-309; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=In vitro test on Philippine isolates of Plasmodium falciparum against four standard antimalarials and four qinghaosu derivatives.; citation_author=MD Boustos; citation_author=F Gay; citation_author=B Diquet; citation_journal_title=Bull WHO; citation_volume=72; citation_number=4; citation_pages=729-735; citation_date=1994; " />
      <meta name="citation_reference" content="citation_title=Cytotoxicity of artemisinin-related endoperoxides to Ehrlich ascites tumor cells.; citation_author=HJ Woerdenbag; citation_author=TA Moskal; citation_author=N Pras; citation_journal_title=J Nat Prod; citation_volume=56; citation_number=5; citation_pages=849-856; citation_date=1993; " />
      <meta name="citation_reference" content="citation_title=Detection of apoptosis in KG-1a leukemic cells treated with investigational drugs.; citation_author=T Efferth; citation_author=G Rücker; citation_author=M Falkenberg; citation_journal_title=Arzneimittelforschung; citation_volume=46; citation_number=6; citation_pages=196-200; citation_date=1996; " />
      <meta name="citation_reference" content="citation_title=The antimalarial artesunate is also active against cancer.; citation_author=T Efferth; citation_author=H Dunstan; citation_author=A Sauerbreys; citation_author=H Miyachi; citation_author=CR Chitambar; citation_journal_title=Int J Oncol; citation_volume=18; citation_number=7; citation_pages=767-773; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=Molecular modes of action of artesunate in tumor cell lines.; citation_author=T Efferth; citation_author=A Sauerbrey; citation_author=A Olbrich; citation_journal_title=Mol Pharmacol; citation_volume=64; citation_number=8; citation_pages=382-394; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells.; citation_author=NP Singh; citation_author=H Lai; citation_journal_title=Life Sci; citation_volume=70; citation_number=9; citation_pages=49-56; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=From mechanistic studies on artemisinin derivatives to new modular antimalarial drugs.; citation_author=A Robert; citation_author=O Dechy-Cabaret; citation_author=J Cazelles; citation_author=B Meunier; citation_journal_title=Acc Chem Res; citation_volume=35; citation_number=10; citation_pages=167-174; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Hemin-catalyzed decomposition of artemisinin.; citation_author=F Zhang; citation_author=DK Gosser; citation_author=SR Meshnick; citation_journal_title=Biochem Pharmacol; citation_volume=43; citation_number=11; citation_pages=1805-1809; citation_date=1992; " />
      <meta name="citation_reference" content="citation_title=Evidence for Fe(IV) = O in the molecular mechanism of action of the trioxane antimalarial artemisinin.; citation_author=GH Posner; citation_author=JN Cumming; citation_author=P Ployprodith; citation_author=CH Oh; citation_journal_title=J Am Chem Soc; citation_volume=117; citation_number=12; citation_pages=5885-5886; citation_date=1995; " />
      <meta name="citation_reference" content="citation_title=Carbon-centered radicals and rational design of new antimalarial peroxide drugs.; citation_author=GH Posner; citation_author=JN Cumming; citation_author=M Krasavin; citation_number=13; citation_pages=289-309; citation_date=2000; citation_publisher=Biomedical Chemistry; " />
      <meta name="citation_reference" content="citation_title=Comparison of transferrin receptors, iron content and isoferritin profile in normal and malignant human breast cell lines.; citation_author=N Shterman; citation_author=B Kupfer; citation_author=C Moroz; citation_journal_title=Pathobiology; citation_volume=59; citation_number=14; citation_pages=19-25; citation_date=1991; " />
      <meta name="citation_reference" content="citation_title=Oral administration of dihydroartemisinin and ferrous sulfate retarded implanted fibrosarcoma growth in the rat.; citation_author=J Moore; citation_author=H Lai; citation_author=JR Li; citation_author=RL Ren; citation_author=JA Mc Dougall; citation_author=NP Singh; citation_author=DK Chou; citation_journal_title=Cancer Lett; citation_volume=98; citation_number=15; citation_pages=83-87; citation_date=1995; " />
      <meta name="citation_reference" content="citation_title=Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron.; citation_author=T Efferth; citation_author=A Benakis; citation_author=MR Romero; citation_journal_title=Free Radic Biol Med; citation_volume=37; citation_number=16; citation_pages=998-1009; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Artemisinin antimalarials: mechanisms of action and resistance.; citation_author=SR Meshnick; citation_journal_title=Med Trop (Mars); citation_number=17; citation_pages=13-17; citation_date=1998; " />
      <meta name="citation_reference" content="citation_title=The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer.; citation_author=TR Daniels; citation_author=T Delgado; citation_author=JA Rodriguez; citation_author=G Helguera; citation_author=ML Penichet; citation_journal_title=Clin Immunol; citation_volume=121; citation_number=18; citation_pages=144-158; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Transferrin receptor expression in nonsmall cell lung cancer. Histopathologic and clinical correlates.; citation_author=JF Whitney; citation_author=JM Clark; citation_author=TW Griffin; citation_author=S Gautam; citation_author=KO Leslie; citation_journal_title=Cancer; citation_volume=76; citation_number=19; citation_pages=20-25; citation_date=1995; " />
      <meta name="citation_reference" content="citation_title=Expression of transferrin receptor and ferritin H-chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer.; citation_author=DC Yang; citation_author=F Wang; citation_author=RL Elliott; citation_author=JF Head; citation_journal_title=Anticancer Res; citation_volume=21; citation_number=20; citation_pages=541-549; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=Prognostic importance of transferrin receptor expression and correlation with K1-67 labelling indices in intracranial meningiomas.; citation_author=T Ucar; citation_author=I Gurer; citation_journal_title=Br J Neurosurg; citation_volume=17; citation_number=21; citation_pages=525-529; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=The role of transporters in cellular heme and porphyrin homeostasis.; citation_author=P Krishnamurthy; citation_author=T Xie; citation_author=JD Schuetz; citation_journal_title=Pharmacol Ther; citation_volume=114; citation_number=22; citation_pages=345-358; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Multiple molecular mechanisms for multidrug resistance transporters.; citation_author=CF Higgins; citation_journal_title=Nature; citation_volume=446; citation_number=23; citation_pages=749-757; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=The human ATP-binding cassette transporter genes: from the bench to the bedside.; citation_author=T Efferth; citation_journal_title=Curr Mol Med; citation_volume=1; citation_number=24; citation_pages=45-65; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=Chemotherapy-induced resistance by ATP-binding cassette transporter genes.; citation_author=JP Gillet; citation_author=T Efferth; citation_author=J Remacle; citation_journal_title=Biochem Biophys Acta – Rev Cancer; citation_volume=1775; citation_number=25; citation_pages=237-262; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Microarray-based detection of multidrug resistance in human tumor cells by expression profiling of ATP-binding cassette transporter genes.; citation_author=JP Gillet; citation_author=T Efferth; citation_author=D Steinbach; citation_journal_title=Cancer Res; citation_volume=64; citation_number=26; citation_pages=8987-8993; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Microarray expression profile of ABC transporters in Human Breast Cancer.; citation_author=JP Gillet; citation_author=J Schneider; citation_author=V Bertholet; citation_author=F de Longueville; citation_author=J Remacle; citation_author=T Efferth; citation_journal_title=Cancer Genomics Proteomics; citation_volume=3; citation_number=27; citation_pages=97-106; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Expression profiling of ATP-binding cassette transporters in childhood T-cell acute lymphoblastic leukemia.; citation_author=T Efferth; citation_author=JP Gillet; citation_author=A Sauerbrey; citation_author=F Zintl; citation_journal_title=Mol Cancer Ther; citation_volume=5; citation_number=28; citation_pages=1986-1994; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=ABCA3 as a possible cause of drug resistance in childhood acute myeloid leukemia.; citation_author=D Steinbach; citation_author=JP Gillet; citation_author=A Sauerbrey; citation_journal_title=Clin Cancer Res; citation_volume=12; citation_number=29; citation_pages=4357-4363; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Human tumor cell lines demonstrating the characteristics of patient tumors as useful models for anticancer drug screening. In: Relevance of tumor models for anticancer drug development.; citation_author=T Roth; citation_author=AM Burger; citation_author=W Dengler; citation_author=H Willmann; citation_author=HH Fiebig; citation_journal_title=Fiebig HH and Burger AM (eds.) Basel, Karger, Contrib Oncol; citation_volume=54; citation_number=30; citation_pages=145-156; citation_date=1999; " />
      <meta name="citation_reference" content="citation_title=Combined in vitro/in vivo test procedure with human tumor xenografts. In: Immunodeficient mice in oncology.; citation_author=HH Fiebig; citation_author=DP Berger; citation_author=WA Dengler; citation_author=E Wallbrecher; citation_author=BR Winterhalter; citation_journal_title=Fiebig HH and Berger DP (eds.) Basel, Karger, Contrib Oncol; citation_volume=42; citation_number=31; citation_pages=321-351; citation_date=1992; " />
      <meta name="citation_reference" content="citation_title=Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.; citation_author=MC Alley; citation_author=DA Scudiero; citation_author=A Monks; citation_journal_title=Cancer Res; citation_volume=48; citation_number=32; citation_pages=589-601; citation_date=1988; " />
      <meta name="citation_reference" content="citation_title=Involvement of ABC7 in the biosynthesis of heme in erythroid cells: interaction of ABC7 with ferrochelatase.; citation_author=S Taketani; citation_author=K Kakimoto; citation_author=H Ueta; citation_author=R Masaki; citation_author=T Furukawa; citation_journal_title=Blood; citation_volume=101; citation_number=33; citation_pages=3274-3280; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines.; citation_author=LV Rubinstein; citation_author=RH Shoemaker; citation_author=KD Paull; citation_journal_title=J Natl Cancer Inst; citation_volume=82; citation_number=34; citation_pages=1113-1118; citation_date=1990; " />
      <meta name="citation_reference" content="citation_title=Development of a propidium iodide fluorescence assay for proliferation and cytotoxicity assay.; citation_author=WA Dengler; citation_author=J Schulte; citation_author=DP Berger; citation_author=R Mertelsmann; citation_author=HH Fiebig; citation_journal_title=Anti-Cancer Drugs; citation_volume=6; citation_number=35; citation_pages=522-532; citation_date=1995; " />
      <meta name="citation_reference" content="citation_title=Microarrays of 41 tumor cell lines for the characterization of new molecular targets: expression patterns of cathepsin B and the transferrin receptor.; citation_author=GJ Wirth; citation_author=K Schandelmaier; citation_author=V Smith; citation_author=AM Burger; citation_author=HH Fiebig; citation_journal_title=Oncology; citation_volume=71; citation_number=36; citation_pages=86-94; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=The multidrug resistance-associated protein 3 (MRP3) is associated with a poor outcome in childhood ALL and may account for the worse prognosis in male patients and T-cell immunophenotype.; citation_author=D Steinbach; citation_author=S Wittig; citation_author=G Cario; citation_journal_title=Blood; citation_volume=102; citation_number=37; citation_pages=4493-4498; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=A gene expression database for the molecular pharmacology of cancer.; citation_author=U Scherf; citation_author=DT Ross; citation_author=M Waltham; citation_journal_title=Nat Genet; citation_volume=24; citation_number=38; citation_pages=236-244; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=Chemosensitivity prediction by transcriptional profiling.; citation_author=JE Staunton; citation_author=DK Slonim; citation_author=HA Coller; citation_journal_title=Proc Natl Acad Sci USA; citation_volume=98; citation_number=39; citation_pages=10787-10792; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells.; citation_author=G Szakacs; citation_author=JP Annereau; citation_author=S Lababidi; citation_journal_title=Cancer Cell; citation_volume=6; citation_number=40; citation_pages=129-137; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Prediction of drug sensitivity and resistance of cancer by protein expression profiling.; citation_author=M Volm; citation_author=R Koomägi; citation_author=T Efferth; citation_journal_title=Cancer Genomics Proteomics; citation_volume=1; citation_number=41; citation_pages=157-166; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Artesunate in the treatment of metastatic uveal melanoma – first experiences.; citation_author=TG Berger; citation_author=D Dieckmann; citation_author=T Efferth; citation_journal_title=Oncol Rep; citation_volume=14; citation_number=42; citation_pages=1599-1603; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=ABC-me: a novel mitochondrial transporter induced by GATA-1 during erythroid differentiation.; citation_author=OS Shirihai; citation_author=T Gregory; citation_author=C Yu; citation_journal_title=EMBO J; citation_volume=19; citation_number=43; citation_pages=2492-2502; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=Mitoxantrone resistance in a small cell lung cancer cell line is associated with ABCA2 upregulation.; citation_author=R Boonstra; citation_author=H Timmer-Bosscha; citation_author=J van Echten-Arends; citation_journal_title=Br J Cancer; citation_volume=90; citation_number=44; citation_pages=2411-2417; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Alteration in copy numbers of genes as a mechanism for acquired drug resistance.; citation_author=K Yasui; citation_author=S Mihara; citation_author=C Zhao; citation_journal_title=Cancer Res; citation_volume=64; citation_number=45; citation_pages=1403-1410; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Gene expression profiling of ATP-binding cassette (ABC) transporters as a predictor of the pathologic response to neoadjuvant chemotherapy in breast cancer patients.; citation_author=S Park; citation_author=C Shimizu; citation_author=T Shimoyama; citation_journal_title=Breast Cancer Res Treat; citation_volume=99; citation_number=46; citation_pages=9-17; citation_date=2006; " />

  <link rel="canonical" href="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0000798" />

    <meta name="twitter:card" content="summary"/>
    <meta name="twitter:site" content="@plosone"/>
    <meta name="twitter:title" content="Role of Transferrin Receptor and the ABC Transporters ABCB6 and ABCB7 for Resistance and Differentiation of Tumor Cells towards Artesunate"/>
    <meta name="twitter:description" content="The anti-malarial artesunate also exerts profound anti-cancer activity. The susceptibility of tumor cells to artesunate can be enhanced by ferrous iron. The transferrin receptor (TfR) is involved in iron uptake by internalization of transferrin and is over-expressed in rapidly growing tumors. The ATP-binding cassette (ABC) transporters ABCB6 and ABCB7 are also involved in iron homeostasis. To investigate whether these proteins play a role for sensitivity towards artesunate, Oncotest's 36 cell line panel was treated with artesunate or artesunate plus iron(II) glycine sulfate (Ferrosanol&reg;). The majority of cell lines showed increased inhibition rates, for the combination of artesunate plus iron(II) glycine sulfate compared to artesunate alone. However, in 11 out of the 36 cell lines the combination treatment was not superior. Cell lines with high TfR expression significantly correlated with high degrees of modulation indicating that high TfR expressing tumor cells would be more efficiently inhibited by this combination treatment than low TfR expressing ones. Furthermore, we found a significant relationship between cellular response to artesunate and TfR expression in 55 cell lines of the National Cancer Institute (NCI), USA. A significant correlation was also found for ABCB6, but not for ABCB7 in the NCI panel. Artesunate treatment of human CCRF-CEM leukemia and MCF7 breast cancer cells induced ABCB6 expression but repressed ABCB7 expression. Finally, artesunate inhibited proliferation and differentiation of mouse erythroleukemia (MEL) cells. Down-regulation of ABCB6 by antisense oligonucleotides inhibited differentiation of MEL cells indicating that artesunate and ABCB6 may cooperate. In conclusion, our results indicate that ferrous iron improves the activity of artesunate in some but not all tumor cell lines. Several factors involved in iron homeostasis such as TfR and ABCB6 may contribute to this effect."/>
      <meta name="twitter:image" content="http://dx.plos.org/10.1371/journal.pone.0000798.g002"/>

  <meta property="og:title" content="Role of Transferrin Receptor and the ABC Transporters ABCB6 and ABCB7 for Resistance and Differentiation of Tumor Cells towards Artesunate" />
  <meta property="og:type" content="article" />
  <meta property="og:url" content="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0000798" />

 <!--end articleInfoX-->

  <link rel="pingback" href="http://www.plosone.org/pingback" />


  <link rel="shortcut icon" href="/images/favicon.ico" type="image/x-icon"/>
  <link rel="home" title="home" href="/"/>
  <link rel="alternate" type="application/rss+xml"
        title="PLOS ONE: New Articles"
        href="http://www.plosone.org/article/feed"/>
</head>
<body>

  <div id="page-wrap">
    <div id="topbanner" class="cf">

<!-- Div for the ad at the top of journal home page-->
<div class="center">
  <div class="title">Advertisement</div>
  <iframe id='a3ac9da4' name='a3ac9da4'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=345&amp;cb=5843'
    frameborder='0' scrolling='no' width='730' height='90'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a3ac9da4&amp;cb=6502'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=345&amp;cb=5688&amp;n=a3ac9da4'
      border='0' alt=''/>
    </a>
  </iframe>
</div>    </div>

    <div id="pagehdr-wrap">
      <div id="pagehdr">
        <div id="user" class="nav">
          <ul>
            <li><a href="http://www.plos.org">plos.org</a></li>
            <li><a href="https://register.plos.org/ambra-registration/register.action">create account</a></li>
            <li class="btn-style"><a
              href="/user/secure/secureRedirect.action?goTo=%2Farticle%2FfetchArticle.action%3FarticleURI%3Dinfo%253Adoi%252F10.1371%252Fjournal.pone.0000798">sign in</a>
            </li>
          </ul>
        </div>
        <div class="logo">
          <a href="/"><img src="/images/logo.png" alt="PLOS ONE"></a>
        </div>

<div id="nav-main" class="nav">
  <ul>
        <li id="mn-01"><a href="/taxonomy" class="areas-link">Subject Areas</a></li>
    <li id="mn-02"><a href="javascript:void(0);">For Authors</a>
      <div class="submenu" style="width: 540px; margin-left: -300px;">
        <div class="block">
          <div class="submit-script">
            <h3>Submit your Manuscript</h3>
            <ul>
              <li>Fair, rigorous peer review</li>
              <li>Broad scope and wide reach</li>
            </ul>
            <a href="/static/submissionInstructions" class="btn">get started</a>
          </div>
        </div>
        <div class="menu">
          <ul>
            <li><a href="/static/publish">Why Publish with PLOS ONE</a></li>
            <li><a href="/static/publication">Publication Criteria</a></li>
            <li><a href="/static/editorial">Editorial Policies</a></li>
            <li><a href="/static/guidelines">Preparing A Manuscript</a></li>
            <li><a href="/static/figureGuidelines">Figure and Table Guidelines</a></li>
          <li><a href="/static/supportingInformation">Supporting Information Guidelines</a></li>
            <li><a href="/static/submissionInstructions">Submitting a Manuscript</a></li>
          </ul>
        </div>
      </div>
    </li>

    <li id="mn-03"><a href="javascript:void(0);">About Us</a>
      <div class="submenu" style="width:248px; margin-left:-30px;">
        <div class="menu">
          <ul>
            <li><a href="/static/information">Journal Information</a></li>
            <li><a href="/static/edboard">Editorial Board</a></li>
            <li><a href="/static/reviewerGuidelines">Reviewer Guidelines</a></li>
            <li><a href="/static/almInfo">Article-Level Metrics</a></li>
            <li><a href="/static/license">Open-Access License</a></li>
            <li><a href="/static/downloads">Media Downloads</a></li>
            <li><a href="/static/commentGuidelines">Guidelines for Comments</a></li>
            <li><a href="/static/corrections">Corrections</a></li>
            <li><a href="/static/help">Help Using this Site</a></li>
            <li><a href="/static/contact">Contact Us</a></li>
          </ul>
        </div>
      </div>
    </li>
  </ul>
<div id="db">
  <form name="searchForm" action="/search/simple?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0000798" method="get" >
<input type="hidden" name="from" value="globalSimpleSearch" id="from"/><input type="hidden" name="filterJournals" value="PLoSONE" id="filterJournals"/>    <fieldset>
      <legend>Search</legend>
      <label for="search">Search</label>
      <div class="wrap">
        <input id="search" type="text" name="query" placeholder="Search">
        <input type="image" alt="SEARCH" src="/images/icon.search.gif">
      </div>
    </fieldset>
  </form>
    <a id="advSearch" href="/search/advanced?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0000798&filterJournals=PLoSONE">advanced search</a>
</div></div>

      </div>
      <!-- pagehdr-->
    </div>
    <!-- pagehdr-wrap -->

  <!--body and html tags gets closed in global_footer.ftl-->
<script type="text/javascript" src="/javascript/mathjax/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>

<div id="pagebdy-wrap">
  <div id="pagebdy">

    <div id="article-block" class="cf">

<div class="article-meta cf">
  <ul id="almSignPost" style="display: none;"></ul>
  <div class="article-type">
    <span class="type oa">Open Access</span>
      <span class="type pr">Peer-Reviewed</span>
  </div>
</div>

<div class="header" id="hdr-article">

<div class="article-kicker">
      <span id="article-type-heading">
        Research Article
      </span>
</div>  <h1 property="dc:title" datatype="" rel="dc:type" href="http://purl.org/dc/dcmitype/Text">
    Role of Transferrin Receptor and the ABC Transporters ABCB6 and ABCB7 for Resistance and Differentiation of Tumor Cells towards Artesunate
  </h1>

  <ul class="authors">
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Gerhard Kelter
              <span class="equal-contrib"
                    title="These authors contributed equally to this work">equal contributor</span>, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">

                <p><span class="equal-contrib" title="These authors contributed equally to this work">equal contributor</span>
                Contributed equally to this work with: Gerhard Kelter, Daniel Steinbach</p>

              
              

                <p>Affiliation:
                  Oncotest GmbH, Institute of Experimental Oncology, Freiburg, Germany
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Daniel Steinbach
              <span class="equal-contrib"
                    title="These authors contributed equally to this work">equal contributor</span>, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">

                <p><span class="equal-contrib" title="These authors contributed equally to this work">equal contributor</span>
                Contributed equally to this work with: Gerhard Kelter, Daniel Steinbach</p>

              
              

                <p>Affiliation:
                  Department for Pediatrics, University of Ulm, Ulm, Germany
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Venkata Badireenath Konkimalla, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Pharmaceutical Biology (C015), German Cancer Research Center, Heidelberg, Germany
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Tsuyoshi Tahara, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Biotechnology, Kyoto Institute of Technology, Kyoto, Japan
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Shigeru Taketani, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Biotechnology, Kyoto Institute of Technology, Kyoto, Japan
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Heinz-Herbert Fiebig, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Oncotest GmbH, Institute of Experimental Oncology, Freiburg, Germany
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Thomas Efferth
              <span class="corresponding">mail</span>
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              <p><span class="email">*</span>To whom correspondence should be addressed. E-mail: <a href="mailto:t.efferth@dkfz.de">t.efferth@dkfz.de</a></p>

                <p>Affiliation:
                  Pharmaceutical Biology (C015), German Cancer Research Center, Heidelberg, Germany
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
  </ul>
  <ul class="date-doi-line">
    <li>Published: August 29, 2007</li>
    <li>DOI: 10.1371/journal.pone.0000798</li>
  </ul>


</div><!--end header-->
<div class="main cf" id="pjax-container">
  

<div class="nav items-5" id="nav-article">
  <ul>
  <li>
        <span class="active" name="article">Article</span>
  </li>
  <li>
      <a href="/article/authors/info%3Adoi%2F10.1371%2Fjournal.pone.0000798" name="authors">About the Authors</a>
  </li>
  <li>
      <a href="/article/metrics/info%3Adoi%2F10.1371%2Fjournal.pone.0000798" name="metrics">Metrics</a>
  </li>
  <li>
      <a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0000798" name="comments">Comments</a>
  </li>
  <li>
      <a href="/article/related/info%3Adoi%2F10.1371%2Fjournal.pone.0000798" name="related">Related Content</a>
  </li>
  </ul>
</div>

<script type="text/javascript">
  var selected_tab = "article";
</script>
  <div id="figure-thmbs" class="carousel cf">
    <div class="wrapper">
      <div class="slider">
              <div class="item">
                <a href="#pone-0000798-t001" data-doi="info:doi/10.1371/journal.pone.0000798" data-uri="info:doi/10.1371/journal.pone.0000798.t001" title="Table 1">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000798.t001&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000798-t002" data-doi="info:doi/10.1371/journal.pone.0000798" data-uri="info:doi/10.1371/journal.pone.0000798.t002" title="Table 2">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000798.t002&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000798-t003" data-doi="info:doi/10.1371/journal.pone.0000798" data-uri="info:doi/10.1371/journal.pone.0000798.t003" title="Table 3">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000798.t003&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000798-g001" data-doi="info:doi/10.1371/journal.pone.0000798" data-uri="info:doi/10.1371/journal.pone.0000798.g001" title="Figure 1">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000798.g001&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000798-g002" data-doi="info:doi/10.1371/journal.pone.0000798" data-uri="info:doi/10.1371/journal.pone.0000798.g002" title="Figure 2">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000798.g002&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
      </div>
    </div>
  </div>

  <div class="nav-col">
    <div class="nav" id="nav-article-page">
      <ul>
        <li class="nav-col-comments"><a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0000798">Reader Comments (1)</a></li>
          <li id="nav-figures"><a data-doi="info:doi/10.1371/journal.pone.0000798" >Figures</a></li>
      </ul>
    </div>
  </div>

  <div class="article">







<div class="abstract"><a id="abstract0" name="abstract0" toc="abstract0" title="Abstract"></a><h2>Abstract</h2><a id="article1.front1.article-meta1.abstract1.p1" name="article1.front1.article-meta1.abstract1.p1"></a><p>The anti-malarial artesunate also exerts profound anti-cancer activity. The susceptibility of tumor cells to artesunate can be enhanced by ferrous iron. The transferrin receptor (TfR) is involved in iron uptake by internalization of transferrin and is over-expressed in rapidly growing tumors. The ATP-binding cassette (ABC) transporters ABCB6 and ABCB7 are also involved in iron homeostasis. To investigate whether these proteins play a role for sensitivity towards artesunate, Oncotest's 36 cell line panel was treated with artesunate or artesunate plus iron(II) glycine sulfate (Ferrosanol®). The majority of cell lines showed increased inhibition rates, for the combination of artesunate plus iron(II) glycine sulfate compared to artesunate alone. However, in 11 out of the 36 cell lines the combination treatment was not superior. Cell lines with high TfR expression significantly correlated with high degrees of modulation indicating that high TfR expressing tumor cells would be more efficiently inhibited by this combination treatment than low TfR expressing ones. Furthermore, we found a significant relationship between cellular response to artesunate and TfR expression in 55 cell lines of the National Cancer Institute (NCI), USA. A significant correlation was also found for <em>ABCB6</em>, but not for <em>ABCB7</em> in the NCI panel. Artesunate treatment of human CCRF-CEM leukemia and MCF7 breast cancer cells induced <em>ABCB6</em> expression but repressed <em>ABCB7</em> expression. Finally, artesunate inhibited proliferation and differentiation of mouse erythroleukemia (MEL) cells. Down-regulation of ABCB6 by antisense oligonucleotides inhibited differentiation of MEL cells indicating that artesunate and ABCB6 may cooperate. In conclusion, our results indicate that ferrous iron improves the activity of artesunate in some but not all tumor cell lines. Several factors involved in iron homeostasis such as TfR and ABCB6 may contribute to this effect.</p>
</div>


<div class="articleinfo"><p><strong>Citation: </strong>Kelter G, Steinbach D, Konkimalla VB, Tahara T, Taketani S, et al.  (2007) Role of Transferrin Receptor and the ABC Transporters ABCB6 and ABCB7 for Resistance and Differentiation of Tumor Cells towards Artesunate. PLoS ONE 2(8):
          e798.
            doi:10.1371/journal.pone.0000798</p><p><strong>Academic Editor: </strong>Mikhail Blagosklonny, Ordway Research Institute, United States of America</p><p><strong>Received:</strong> May 18, 2007; <strong>Accepted:</strong> July 30, 2007; <strong>Published:</strong> August 29, 2007</p><p><strong>Copyright:</strong> © 2007 Kelter et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p><p><strong>Funding: </strong>This work was funded by intramural grants.</p><p><strong>Competing interests:</strong> The authors have declared that no competing interests exist.</p></div>





<div id="section1" class="section"><a id="s1" name="s1" toc="s1" title="Introduction"></a><h3>Introduction</h3><a id="article1.body1.sec1.p1" name="article1.body1.sec1.p1"></a><p>Artemisinin is a sesquiterpene isolated from <em>Artemisia annua</em> L., which is used in traditional Chinese medicine for the treatment of fever and chills <a href="#pone.0000798-Klayman1">[1]</a>. Artemisinin reveals profound activity against <em>Plasmodium falciparum</em> and <em>Plasmodium vivax</em> <a href="#pone.0000798-Ashley1">[2]</a>, <a href="#pone.0000798-Efferth1">[3]</a>. Artesunate and artemether are semi-synthetic derivatives of artemisinin with improved pharmacological features <a href="#pone.0000798-Boustos1">[4]</a>. In addition to their anti-malarial activity, artemisinin and its derivatives are also active against cancer cells <a href="#pone.0000798-Woerdenbag1">[5]</a>–<a href="#pone.0000798-Singh1">[9]</a>. In both cases, the activity of the drugs is associated with the presence of iron. Iron is present in large excess bound to hemoglobin in erythrocytes, where the <em>Plasmodia</em> parasites are located. The active moiety of artemisinin-like drugs is an endoperoxide bridge, whose reductive homolysis is promoted by iron(II)-heme leading to C4-centered alkylating radicals <a href="#pone.0000798-Robert1">[10]</a>. These radical molecules cause macromolecular damage by alkylating essential malarial proteins inducing cell death of parasites <a href="#pone.0000798-Zhang1">[11]</a>–<a href="#pone.0000798-Posner2">[13]</a>. On the other hand, iron content is higher in tumor cells than in normal cells <a href="#pone.0000798-Shterman1">[14]</a> making them more susceptible to artemisinins. We and others have shown that the susceptibility of tumor cells to artemisinins can further be enhanced by the addition of transferrin or ferrous iron <a href="#pone.0000798-Moore1">[15]</a>, <a href="#pone.0000798-Efferth5">[16]</a>.</p>
<a id="article1.body1.sec1.p2" name="article1.body1.sec1.p2"></a><p>The role of artemisinins and iron for malaria treatment has been intensively investigated during the past years <a href="#pone.0000798-Meshnick1">[17]</a>, whereas the role of iron for tumor treatment with artemisinins is far less understood. The iron-binding protein, transferrin, is internalized into cancer cells after binding to the transferrin receptor (TfR, CD71). This is a transmembrane glycoprotein involved in iron uptake by internalization of transferrin. TfR exerts growth regulatory functions and is over-expressed in rapidly growing tumors <a href="#pone.0000798-Daniels1">[18]</a>. The expression of TfR is of prognostic significance for several tumor types <a href="#pone.0000798-Whitney1">[19]</a>–<a href="#pone.0000798-Ucar1">[21]</a>. Ferrous iron can either be bound to transferrin or to other proteins before uptake.</p>
<a id="article1.body1.sec1.p3" name="article1.body1.sec1.p3"></a><p>The ATP-binding cassette (ABC) transporters ABCB6 and ABCB7 are involved in iron homeostasis. They are located in the mitochondria and transport heme and protoporphyrins into these organelles <a href="#pone.0000798-Krishnamurthy1">[22]</a>. Most ABC transporters are involved in the active transport of phospholipids, ions, peptides, steroids, polysaccharides, amino acids, bile acids, pharmaceutical drugs and other xenobiotic compounds <a href="#pone.0000798-Higgins1">[23]</a>.</p>
<a id="article1.body1.sec1.p4" name="article1.body1.sec1.p4"></a><p>In humans, 49 different ABC transporters have been identified, which are classified into seven sub-families (A–G) <a href="#pone.0000798-Efferth6">[24]</a>. In healthy organs several ABC transporters protect against the harmful effects of xenobiotics taken up with food. A high expression can, therefore, be found in the gastrointestinal tract, liver, and kidney. A protective function is also given as components of the blood brain barrier and the blood placenta barrier.</p>
<a id="article1.body1.sec1.p5" name="article1.body1.sec1.p5"></a><p>ABC transporters have been intensively investigated in the past years. ABCB1 (P-glycoprotein, <em>MDR1</em>), ABCC1-C6 (MRP1-6) and ABCG2 (BCRP) confer resistance to cytostatic drugs of tumors and contribute to the failure of tumor chemotherapy <a href="#pone.0000798-Gillet1">[25]</a>. The mutated gene product of ABCC7 (CFTR) is involved in the pathogenesis cystic fibrosis, and some other mutated ABC transporter genes contribute to a number of hereditary diseases and disorders <a href="#pone.0000798-Efferth6">[24]</a>. The pathogenic function of the majority of ABC transporters still awaits elucidation. To gain insight into functional aspects, we have developed a low density microarray for ABC transporters <a href="#pone.0000798-Gillet2">[26]</a>, <a href="#pone.0000798-Gillet3">[27]</a>. Applying this microarray, we identified ABCA2 and ABCA3 as further genes involved in tumor drug resistance <a href="#pone.0000798-Efferth7">[28]</a>, <a href="#pone.0000798-Steinbach1">[29]</a>.</p>
<a id="article1.body1.sec1.p6" name="article1.body1.sec1.p6"></a><p>In the present investigation, we focused on TfR, ABCB6, and ABCB7. The aim of the present study was to address the question, whether these proteins are involved in the response of tumor cells to artesunate.</p>
</div>

<div id="section2" class="section"><a id="s2" name="s2" toc="s2" title="Materials and Methods"></a><h3>Materials and Methods</h3>
<h4>Drugs</h4>
<a id="article1.body1.sec2.sec1.p1" name="article1.body1.sec2.sec1.p1"></a><p>Artesunate was obtained from Saokim Ltd. (Hanoi, Vietnam) and iron(II) glycine sulfate (Ferrosanol®) from Sanol (Munich, Germany).</p>


<h4>Cell Lines</h4>
<a id="article1.body1.sec2.sec2.p1" name="article1.body1.sec2.sec2.p1"></a><p>CCRF-CEM were cultured in RPMI medium and MCF-7 and MEL cells in DMEM medium each supplemented with 10% fetal calf serum under standard conditions (37°C, 5% CO<sub>2</sub>). Cells were passaged twice weekly.</p>
<a id="article1.body1.sec2.sec2.p2" name="article1.body1.sec2.sec2.p2"></a><p>Twenty-four cell lines out of Oncotest's 36 cell line panel were established at Oncotest from patient-derived tumor xenografts passaged subcutaneously in nude mice <a href="#pone.0000798-Roth1">[30]</a>. The origin of the donor xenografts have been previously described <a href="#pone.0000798-Fiebig1">[31]</a>. The cell lines T24, Panc1 and 22RV1 were obtained from ATCC (Rockville, MD, USA), the cell line LnCAP from DSMZ (Braunschweig, Germany) and the other 8 cell lines were kindly provided by the National Cancer Institute (Bethesda, MA, USA).</p>
<a id="article1.body1.sec2.sec2.p3" name="article1.body1.sec2.sec2.p3"></a><p>The cultivation of 55 cell lines (leukemia, melanoma, non-small cell lung cancer, colon cancer, renal cancer, ovarian cancer, brain tumors, prostate cancer, and breast cancer) of the Developmental Therapeutics Program of the NCI has been previously described <a href="#pone.0000798-Alley1">[32]</a>.</p>


<h4>Effect on cell growth</h4>
<a id="article1.body1.sec2.sec3.p1" name="article1.body1.sec2.sec3.p1"></a><p>MEL cells were cultured with and without 1.0 µg/ml artesunate (2.6 µM) for 24 and 48 h. Cell numbers were determined by trypan blue exclusion.</p>


<h4>Effect on differentiation</h4>
<a id="article1.body1.sec2.sec4.p1" name="article1.body1.sec2.sec4.p1"></a><p>MEL cells (1×10<sup>6</sup> cells/ml) were cultures in the presence of 2% DMSO with or without 1.0 µg/ml artesunate (2.6 µM) for 28h. The content of heme was estimated by the conversion of heme to protoporphyrin with oxalic acid <a href="#pone.0000798-Taketani1">[33 Taketani et al., 2003]</a>.</p>


<h4>Sulforhodamine B assay</h4>
<a id="article1.body1.sec2.sec5.p1" name="article1.body1.sec2.sec5.p1"></a><p><em>D</em>rug sensitivity of the NCI cell lines has been determined by the sulforhodamine B assay <a href="#pone.0000798-Rubinstein1">[34 Rubinstein et al., 1990]</a>. The 50% inhibition concentration (IC<sub>50</sub>) values for artesunate have been reported <a href="#pone.0000798-Efferth3">[7]</a> and those of other anti-cancer drugs have been deposited in the database of the NCI database (<a href="http://dtp.nci.nih.gov">http://dtp.nci.nih.gov</a>).</p>


<h4>Propidium iodide (PI) assay</h4>
<a id="article1.body1.sec2.sec6.p1" name="article1.body1.sec2.sec6.p1"></a><p>A modified propidium iodide assay <a href="#pone.0000798-Dengler1">[35]</a> was used to assess the compound's activity in Oncotest's 36 cell line panel. Briefly, cells were harvested from exponential phase cultures by trypsinization, counted and plated in 96 well flat-bottomed micro-titer plates at a cell density depending on the cell line (4.000–10.000 cells/well). After a 24 h recovery period to allow the cells to adhere and resume exponential growth, 10 µl of culture medium (six control wells/plate) or of culture medium containing the test compounds were added to the cells. The compounds were applied in triplicates at five concentrations. Following four days of continuous drug exposure, medium or medium with test compound, including all dead cells suspended in the culture medium, was aspirated and replaced by 200 µl of an aqueous propidium iodide (PI) solution (7 µg/ml). To measure the amount of living cells, cells were permeabilized by freezing the plates, resulting in the death of all cells that had remained attached to the bottom of the well after the incubation period. After thawing of the plates, fluorescence was measured using the Cytofluor 4000 micro-plate reader (excitation 530 nm, emission 620 nm), providing a direct relationship to the total viable cell number.</p>


<h4>Cell line array</h4>
<a id="article1.body1.sec2.sec7.p1" name="article1.body1.sec2.sec7.p1"></a><p>Arrays of cell lines from the Oncotest Human Cell Line Collection were assembled using a tissue arrayer (Beecher Instruments, Sun Prairie, Wisc., USA) as recently described <a href="#pone.0000798-Wirth1">[36]</a>. Pellet biopsies (0.6 mm in diameter) were taken from embedded cells and arrayed in duplicate in a new recipient paraffin block. Four-micrometer sections of the resulting microarray block were cut and transferred onto glass slides using the paraffin-sectioning aid system (Instrumedics, Hackensack, NJ, USA) and further processed for immunohistochemical staining. The arrays were stained with the primary antibody 71C03 against TfR (Neomarkers, Fremont, CA, USA). Staining was analyzed by light microscopy and semi-quantitatively evaluated as described <a href="#pone.0000798-Wirth1">[36]</a>.</p>


<h4>Quantitative real-time PCR</h4>
<a id="article1.body1.sec2.sec8.p1" name="article1.body1.sec2.sec8.p1"></a><p>Quantitative PCR was done as described <a href="#pone.0000798-Steinbach2">[37]</a>. The ABI Prism 7700 Sequence Detector and Pre-Developed Assay Reagents (Applied Biosystems, Weiterstadt, Germany) were used for the quantification of all genes. The expression of the ABC transporters was standardized for the expression of two housekeeping genes, β-2-microglobulin (B2M) and Abelson gene 1 (ABL1). The ABI Prism 7700 Sequence Detector and Pre-Developed Assay Reagents (Applied Biosystems, Weiterstadt, Germany) were used for the quantification of all genes. The assay IDs were: B2M: Hs00187842_m1; ABL1: Hs00245445_m1; ABCB6: Hs00180568_m1 and ABCB7: Hs00188776_m1.</p>


<h4>Western blotting</h4>
<a id="article1.body1.sec2.sec9.p1" name="article1.body1.sec2.sec9.p1"></a><p>MEL cells (1×10<sup>6</sup> cells/ml) were cultured in the presence of 2% DMSO. After 24, 48, 72, or 96 h the cells were collected and lysed. The cellular proteins were analyzed by SDS-PAGE and transferred onto PVDF membranes. Immunoblotting was performed with antibodies for ABCB6, ABCB7, and actin as the primary antibodies <a href="#pone.0000798-Taketani1">[33]</a>.</p>


<h4>Transfection of oligonucleotides</h4>
<a id="article1.body1.sec2.sec10.p1" name="article1.body1.sec2.sec10.p1"></a><p>Phosphorothioate sense and antisense oligonucleotides corresponding to the mouse ABCB6 gene were transfected using DOTAP transfection reagent (Roche Molecular Biochemicals, Mannheim, Germany) as described <a href="#pone.0000798-Taketani1">[33]</a></p>


<h4>Statistics</h4>
<a id="article1.body1.sec2.sec11.p1" name="article1.body1.sec2.sec11.p1"></a><p><em>Fisher's exact test</em> was used to calculate significance values as a measure for the dependency of two variables. This test was implemented into the WinSTAT Program (Kalmia, Cambridge, MA, U.S.A.). The TfR expression in the Oncotest panel of tumor cell lines has been determined by a tissue micro-array technique adapted for the examination of cell line and immunohistochemistry <a href="#pone.0000798-Wirth1">[36]</a>. The results have been validated by conventional immunohistochemistry and Western blotting <a href="#pone.0000798-Wirth1">[36]</a>. The mRNA expression values for <em>TFR</em> (clone M11507, GC102405) determined by microarray analysis <a href="#pone.0000798-Scherf1">[38]</a>, <a href="#pone.0000798-Staunton1">[39]</a> were selected from the NCI database (<a href="http://dtp.nci.nih.gov">http://dtp.nci.nih.gov</a>). The microarray-based expression levels of <em>ABCB6</em> and <em>ABCB7</em> have been validated by RT-PCR <a href="#pone.0000798-Szakacs1">[40]</a>.</p>

</div>

<div id="section3" class="section"><a id="s3" name="s3" toc="s3" title="Results"></a><h3>Results</h3>
<h4>Transferrin Receptor (TfR)</h4>
<a id="article1.body1.sec3.sec1.p1" name="article1.body1.sec3.sec1.p1"></a><p>To investigate the role of TfR and iron for cellular sensitivity to artesunate, Oncotest's 36 cell line panel was used. The 50% inhibition concentrations (IC<sub>50</sub>) for artesunate are shown in <a href="#pone-0000798-t001"><strong>Table 1</strong></a>. The IC<sub>50</sub> values varied between 0.197 and 47.779 µg/ml (0.512 and 124.295 µM respectively). The mean IC<sub>50</sub> value was 2.791 µg/ml (7.261 µM). Furthermore, we tested a combination of artesunate and iron(II) glycine sulfate (10 µg/ml; Ferrosanol®) (<a href="#pone-0000798-t001"><strong>Table 1</strong></a>). Here, the mean IC<sub>50</sub> value was 0.978 µg/ml (2.544 µM) with a range from 0.013 and 22.96 µg/ml (0.026 and 59.748 µM, respectively). The data in <a href="#pone-0000798-t001"><strong>Table 1</strong></a> are arranged according to the IC<sub>50</sub> values for artesunate. In the majority of cell lines, the combination of artesunate plus iron(II) glycine sulfate resulted increased inhibition rates. However, in 11 out of the 36 cell lines (31%; OVXF 1619L, CNXF, 498NL, MCF7, RXF 393NL, MEXF 514L, MEXF 394NL, LXFL 529L, H460, 22RV1, RXF1781L, OVXL 899L) the combination treatment was not superior to treatment with artesunate alone (degree of modulation &lt;1.2). Furthermore, degrees of modulation (IC<sub>50</sub> for artesunate divided by the IC<sub>50</sub> for artesunate plus iron(II) glycine sulfate) did not correlate with IC<sub>50</sub> values for artesunate, e.g. cell lines with high IC<sub>50</sub> values for artesunate were not more modulated by the addition of iron(II) glycine sulfate than cell lines with low IC<sub>50</sub> values for artesunate (<a href="#pone-0000798-t001"><strong>Table 1</strong></a>).</p>
<div class="figure" id="pone-0000798-t001"><div class="img"><a name="pone-0000798-t001" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000798.t001&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000798" data-uri="info:doi/10.1371/journal.pone.0000798.t001"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000798.t001&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000798.t001/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000798.t001/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000798.t001/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000798.t001/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000798.t001.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000798.t001/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000798.t001/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000798.t001.TIF"></span>)
                </a></li></ul></div><p><strong>Table 1.  <span>TfR expression and in vitro anti-tumor activity of artesunate alone and in combination with iron(II) glycine sulfate (Ferrosanol®, 10 µg/ml) in Oncotest's 36 cell line panel.</span></strong></p><span>doi:10.1371/journal.pone.0000798.t001</span></div><a id="article1.body1.sec3.sec1.p2" name="article1.body1.sec3.sec1.p2"></a><p>Then, we correlated the expression of TfR with the degrees of modulation. We found that cell lines with high TfR expression significantly correlated with high degrees of modulation (<a href="#pone-0000798-t002"><strong>Table 2</strong></a>) indicating that high TfR expressing tumor cells could be more efficiently inhibited by a combination of artesunate and iron(II) glycine sulfate than low TfR expressing ones. TfR expression did not correlate with IC<sub>50</sub> values for artesunate alone or artesunate plus iron(II) glycine sulfate.</p>
<div class="figure" id="pone-0000798-t002"><div class="img"><a name="pone-0000798-t002" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000798.t002&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000798" data-uri="info:doi/10.1371/journal.pone.0000798.t002"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000798.t002&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000798.t002/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000798.t002/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000798.t002/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000798.t002/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000798.t002.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000798.t002/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000798.t002/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000798.t002.TIF"></span>)
                </a></li></ul></div><p><strong>Table 2.  <span>Relationship between transferrin receptor (TfR) protein expression and degree of modulation to a combination therapy of artesunate plus iron(II) glycine sulfate (see Table I) in tumor cell lines of the Oncotest panel.</span></strong></p><span>doi:10.1371/journal.pone.0000798.t002</span></div><a id="article1.body1.sec3.sec1.p3" name="article1.body1.sec3.sec1.p3"></a><p>Furthermore, we investigated the association of <em>TFR</em> for sensitivity or resistance to artesunate in 55 cell lines of the NCI drug screening panel. We found a significant relationship between cellular response to artesunate and <em>TFR</em> expression (<a href="#pone-0000798-t003"><strong>Table 3</strong></a>) indicating that <em>TFR</em> might be a determinant of artesunate sensitivity in tumor cells.</p>
<div class="figure" id="pone-0000798-t003"><div class="img"><a name="pone-0000798-t003" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000798.t003&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000798" data-uri="info:doi/10.1371/journal.pone.0000798.t003"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000798.t003&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000798.t003/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000798.t003/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000798.t003/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000798.t003/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000798.t003.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000798.t003/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000798.t003/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000798.t003.TIF"></span>)
                </a></li></ul></div><p><strong>Table 3.  <span>Relationship between transferrin receptor (<em>TFR</em>), <em>ABCB6</em>, and <em>ABCB7</em> mRNA expression and response to artesunate (ART) in tumor cell lines of the NCI drug screening panel.</span></strong></p><span>doi:10.1371/journal.pone.0000798.t003</span></div>

<h4>ABCB6 and ABCB7</h4>
<a id="article1.body1.sec3.sec2.p1" name="article1.body1.sec3.sec2.p1"></a><p>Since ABCB6 and ABCB7 are involved in iron homeostasis of cells, we investigated a role of these two proteins for cellular response to artesunate. Again, we used the IC<sub>50</sub> values for artesunate of 55 NCI cell lines. These data were correlated with the microarray-based expression of <em>ABCB6</em> (clone AF070598, GC56272) and <em>ABCB7</em> (clone AA056272, GC10226). As shown in <a href="#pone-0000798-t003"><strong>Table 3</strong></a>, a significant correlation was found for <em>ABCB6</em>, but not for <em>ABCB7</em>.</p>
<a id="article1.body1.sec3.sec2.p2" name="article1.body1.sec3.sec2.p2"></a><p>Then, MCF-7 breast cancer cells and CCRF-CEM leukemia cells were incubated with artesunate in a range of 0.05 to 50 µg/ml (0.13 to 130 µM respectively) for 24 h. Afterwards, mRNA was isolated and the expression of <em>ABCB6</em> and <em>ABCB7</em> determined by real time PCR. As can be seen in <a href="#pone-0000798-g001"><strong>Figure 1</strong></a> the expression of <em>ABCB6</em> increased with increasing doses of artesunate, while the expression of <em>ABCB7</em> decreased accordingly. The induction of gene expression by artesunate might indicate a role of these two genes for cellular response to artesunate treatment. This can, however, not be taken as evidence, that the two genes are causatively related to artesunate response, and an epiphenomenal association can not be excluded.</p>
<div class="figure" id="pone-0000798-g001"><div class="img"><a name="pone-0000798-g001" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000798.g001&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000798" data-uri="info:doi/10.1371/journal.pone.0000798.g001"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000798.g001&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000798.g001/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000798.g001/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000798.g001/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000798.g001/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000798.g001.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000798.g001/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000798.g001/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000798.g001.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 1.  <span>Expression of ABCB6 and ABCB7 in MCF7 (A.) and CCRF-CEM cells (B.) after treatment with artesunate.</span></strong></p><a id="article1.body1.sec3.sec2.fig1.caption1.p1" name="article1.body1.sec3.sec2.fig1.caption1.p1"></a><p>The expression after 24 hours is given in relation to the expression before treatment.</p>
<span>doi:10.1371/journal.pone.0000798.g001</span></div><a id="article1.body1.sec3.sec2.p3" name="article1.body1.sec3.sec2.p3"></a><p>Finally, we treated MEL cells with artesunate (1 µg/ml, 2.6 µM). Mouse erythroleukemia (MEL) cells were used as model to study the role of ABCB6 and ABCB7 during cellular differentiation. While cell growth was almost stopped, only 20% of cells died (<a href="#pone-0000798-g002"><strong>Figure 2A</strong></a>). Treatment of MEL cells with 2% DMSO leads to erythroid differentiation and heme production (33). DMSO also induced the expression of ABCB6 and ABCB7 proteins (<a href="#pone-0000798-g002"><strong>Figure 2B</strong></a>). Furthermore, the addition of artesunate completely blocked DMSO-induced erythroid differentiation in MEL cells in a dose-dependent manner (<a href="#pone-0000798-g002"><strong>Figure 2B</strong></a>). Under these conditions most cells were alive. This indicates that artesunate is a potent inhibitor of proliferation and differentiation in MEL cells. Artesunate induced protein expression of both ABCB6 and ABCB7 (<a href="#pone-0000798-g002"><strong>Figure 2C</strong></a>).</p>
<div class="figure" id="pone-0000798-g002"><div class="img"><a name="pone-0000798-g002" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000798.g002&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000798" data-uri="info:doi/10.1371/journal.pone.0000798.g002"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000798.g002&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000798.g002/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000798.g002/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000798.g002/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000798.g002/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000798.g002.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000798.g002/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000798.g002/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000798.g002.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 2.  <span>Effect of artesunate on MEL cell proliferation, differentiation, and ABCB6/ABCB7 expression.</span></strong></p><a id="article1.body1.sec3.sec2.fig2.caption1.p1" name="article1.body1.sec3.sec2.fig2.caption1.p1"></a><p>A. Effect on cell growth. MEL cells were cultured without or with 1.0 µg/ml artesunate for the indicated time. The cell numbers were measured by trypan blue exclusion. B. Protein expression of ABCB6 and ABCB7 after treatment with 2% DMSO for different time points. Actin expression served as loading control. C. Effect on differentiation. MEL cells (100,000 cells/ml) were cultured in the presence of various concentrations of artesunate for 48 h. The content of heme was estimated, by the method with oxalic acid. D. The cells transfected with sense- or antisense oligonucleotides for ABCB6 were induced with 2% DMSO without or with 0.18 µg/ml artesunate for 48 h.</p>
<span>doi:10.1371/journal.pone.0000798.g002</span></div><a id="article1.body1.sec3.sec2.p4" name="article1.body1.sec3.sec2.p4"></a><p>The IC<sub>50</sub> value regarding heme production for artesunate in MEL cells was 0.18 µg/ml (0.468 µM). We previously reported that an antisense oligonucleotide directed against ABCB6 depressed the erythroid differentiation of MEL cells to 75% <a href="#pone.0000798-Taketani1">[33]</a>. When MEL cells were transfected with this antisense oligonucleotide and treated with artesunate (0.18 µg/ml, 0.468 µM) in combination, the heme content decreased to about 30% control (<a href="#pone-0000798-g002"><strong>Figure 2D</strong></a>). This indicates an additive effect.</p>

</div>

<div id="section4" class="section"><a id="s4" name="s4" toc="s4" title="Discussion"></a><h3>Discussion</h3><a id="article1.body1.sec4.p1" name="article1.body1.sec4.p1"></a><p>The aim of the present study was to explore the role of proteins related to iron homeostasis for response of tumor cells to artesunate. For this purpose, we focused on TfR and the ABC transporters, ABCB6 and ABCB7.</p>
<a id="article1.body1.sec4.p2" name="article1.body1.sec4.p2"></a><p>We observed a wide heterogeneity of tumor cell lines towards artesunate. Whereas iron(II) glycine sulfate was able to increase sensitivity of tumor cells to artesunate in most cell lines, there was no correlation between the IC<sub>50</sub> values and high degrees of modulation by iron(II) glycine sulfate. This indicates that iron(II) glycine sulfate is not a typical resistance modulator comparable to modulators of multidrug resistance, where modulating agents completely or partially overcome resistance of a drug-resistant sub-line to a cytostatic drug towards the level of a parental drug-sensitive cell line <a href="#pone.0000798-Gillet1">[25]</a>.</p>
<a id="article1.body1.sec4.p3" name="article1.body1.sec4.p3"></a><p>It is important to point out that several cell lines did not show increased inhibition by the combination of artesunate and iron(II) glycine sulfate compared to artesunate alone. Some of these cell lines did even reveal decreased efficacy to artesunate under co-treatment with iron(II) glycine sulfate. Iron is an important regulator of cell growth and tumor cells may take advantage of external iron supply to grow faster. Iron(II) glycine sulfate is an approved drug, Ferrosanol® applied for many years in the clinic to treat iron deficiency. Therefore, iron(II) glycine sulfate seems to be a safe and suitable adjunct for combination treatments with artesunate at first sight. Our results do, however, indicate that there may be patients, who would not profit from addition of iron(II) glycine sulfate during artesunate treatment. In this context, iron(II) glycine sulfate is a double edged sword improving treatment response in the majority of tumor cell lines but worsening it in others. Other iron preparations have also been reported to improve the response of tumor cells to artemisinins, e.g. ferrous sulfate or iron-loaded transferring (holotransferrin) <a href="#pone.0000798-Singh1">[9]</a>, <a href="#pone.0000798-Moore1">[15]</a>. It remains to be analyzed, whether the same is true for these iron preparations.</p>
<a id="article1.body1.sec4.p4" name="article1.body1.sec4.p4"></a><p>The fact that in some cases iron(II) gylcine sulfate could also lead to reduced response of tumor cells towards artesunate opens an option for the testing of tumors before treatment in a clinical setting. If predictive tests, e.g., determination of TfR expression or sensitivity testing by MTT assay, indicate enhanced sensitivity, a combination therapy of artesunate and iron(II) glycine sulfate could be applied. If this is not the case, iron(II) glycine sulfate could be skipped, and artesunate could be applied alone. This situation adds to the attractiveness of individualized tumor therapy. The main idea of this concept is to adapt treatment protocols of each individual patient according to the results of pre-therapeutic testing of efficacy of a planned therapy <a href="#pone.0000798-Volm1">[41]</a>.</p>
<a id="article1.body1.sec4.p5" name="article1.body1.sec4.p5"></a><p>On the other hand, three out of the five melanoma cell lines were clearly above-average sensitive to artesunate (individual IC<sub>50</sub>&lt;4.2 µM), and both more resistant melanomas (IC<sub>50</sub>&gt;12 µM) were strongly sensitized (degree of modulation &gt;15) by the addition of iron(II) glycine sulfate indicating that this entity is especially suited for this treatment regimen. Interestingly, these results are supported by recent clinical data. Artesunate has been applied to two patients with otherwise drug-resistant and refractory uveal mealoma <a href="#pone.0000798-Berger1">[42]</a>. The prognosis of refractory uveal melanoma patients is generally worse (3–5 months). One artesunate treated patient with uveal melanoma had a stable disease following artesunate treated, but finally the tumor progressed and the patient died after 24 months. The second patients with uveal melanoma was treated with artesunate plus iron(II) glycine sulfate and is still living after more than 50 months <a href="#pone.0000798-Berger1">[42]</a>. This may be taken as a clue that the combination of artesunate plus iron(II)glycine sulfate is indeed especially suited for this tumor type. Further analyses have to prove this hypothesis.</p>
<a id="article1.body1.sec4.p6" name="article1.body1.sec4.p6"></a><p>Interestingly, the expression of <em>TFR</em> correlated with IC<sub>50</sub> values for artesunate alone in the panel of 55 NCI cell lines, but not in the panel of 36 Oncotest cell lines. This is a clue that <em>TFR</em> expression is only one determinant of response of tumor cells towards artesunate. While endogenous iron might contribute to artesunate sensitivity, exogenous iron application during artesunate treatment is favorable for those tumors with high <em>TFR</em> expression levels.</p>
<a id="article1.body1.sec4.p7" name="article1.body1.sec4.p7"></a><p>In addition to TfR, iron is transported in cells by ABCB6 and ABCB7. Therefore, we also investigated the role of these two proteins for treatment of tumor cells with artesunate. ABCB6 is involved in the biosynthesis of heme via interaction with ferrochelatase, which is regulated by iron <a href="#pone.0000798-Taketani1">[33]</a>. We found that the microarray-based mRNA expression of <em>ABCB6</em> but not of <em>ABCB7</em> correlated with IC<sub>50</sub> values for artesunate in the NCI cell line panel. While <em>ABCB6</em> was induced upon artesunate treatment in MCF7 and CCRF-CEM cells, <em>ABCB7</em> expression was down-regulated. These results speak at least in the case of ABCB6 for a role in determining sensitivity to artesunate.</p>
<a id="article1.body1.sec4.p8" name="article1.body1.sec4.p8"></a><p>In addition to the anti-proliferative activity of artesunate on tumor cells, we also analyzed its effect on differentiation. For this reason, we used MEL cells, which are an established model to study ABCB6 and ABCB7 during cellular differentiation <a href="#pone.0000798-Shirihai1">[43]</a>. DMSO induced both differentiation and up-regulation of ABCB6 and ABCB7 protein expression. Artesunate was able to reverse DMSO-induced differentiation was measured by cellular heme production. Down-regulation of ABCB6 by transfection with antisense oligonucleotides inhibited DMSO-induced heme biosynthesis indicating that this protein might play a role in differentiation.</p>
<a id="article1.body1.sec4.p9" name="article1.body1.sec4.p9"></a><p>The role of ABCB6 and ABCB7 for drug resistance has been sparsely investigated as of yet. Boonstra et al. <a href="#pone.0000798-Boonstra1">[44]</a> did not find that ABCB6 expression in small lung cancer cells was associated with resistance to mitoxantrone. Thirteen different ABC transporters including ABCB6 and different anti-apoptotic Bcl2 gene family members were reported to be amplified in various drug-resistant cell lines <a href="#pone.0000798-Yasui1">[45]</a>. While the other factors may contribute to clinical response towards neo-adjuvant chemotherapy, the specific role of ABCB6 remains unanswered in this study. Park et al. <a href="#pone.0000798-Park1">[46]</a> analyzed the ABC transporter gene expression profiles in breast cancer patients who underwent neo-adjuvant chemotherapy. Several ABC transporters including ABCB6 showed significantly increase expression in residual disease. Again, the role of ABCB6 remains elusive. An association between ABCB7 and drug resistance has not been reported yet.</p>
<a id="article1.body1.sec4.p10" name="article1.body1.sec4.p10"></a><p>In conclusion, our results indicate that ferrous iron improves the activity of artesunate in some but not all tumor cell lines. Several factors involved in iron homeostasis such as TfR and ABCB6 may contribute to this effect. It remains to be analyzed, whether other factors of iron metabolism (ferrochelatase, ferritin etc) are also relevant for response of tumor cells towards artesunate</p>
</div>



<div class="contributions"><a id="authcontrib" name="authcontrib" toc="authcontrib" title="Author Contributions"></a><h3>Author Contributions</h3><p>Conceived and designed the experiments: HF. Performed the experiments: TT VK ST GK. Analyzed the data: HF. Wrote the paper: TE DS.</p></div><div><a id="references" name="references" toc="references" title="References"></a><h3>References</h3><ol class="references"><li><span class="label">1.
              </span><a name="pone.0000798-Klayman1" id="pone.0000798-Klayman1"></a>Klayman DL (1985) Qinghaosu (artemisinin): an antimalarial drug from China. Science  228: 1049–1055.  <ul class="find" data-citedArticleID="983322" data-doi="10.1126/science.3887571"><li><a href="http://dx.doi.org/10.1126/science.3887571" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Qinghaosu+%28artemisinin%29%3A+an+antimalarial+drug+from+China." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Qinghaosu+%28artemisinin%29%3A+an+antimalarial+drug+from+China.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">2.
              </span><a name="pone.0000798-Ashley1" id="pone.0000798-Ashley1"></a>Ashley EA, White NJ (2007) Artemisinin-based combinations. Curr Opin Infect Dis  18: 531–536.  <ul class="find" data-citedArticleID="983286" data-doi="10.1097/01.qco.0000186848.46417.6c"><li><a href="http://dx.doi.org/10.1097/01.qco.0000186848.46417.6c" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Artemisinin-based+combinations." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Artemisinin-based+combinations.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">3.
              </span><a name="pone.0000798-Efferth1" id="pone.0000798-Efferth1"></a>Efferth T (2007) Willmar Schwabe Award 2006: antiplasmodial and antitumor activity of artemisinin–from bench to bedside. Planta Med  73: 299–309.  <ul class="find" data-citedArticleID="983298" data-doi="10.1055/s-2007-967138"><li><a href="http://dx.doi.org/10.1055/s-2007-967138" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Willmar+Schwabe+Award+2006%3A+antiplasmodial+and+antitumor+activity+of+artemisinin%26%23x2013%3Bfrom+bench+to+bedside." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Willmar+Schwabe+Award+2006%3A+antiplasmodial+and+antitumor+activity+of+artemisinin%26%23x2013%3Bfrom+bench+to+bedside.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">4.
              </span><a name="pone.0000798-Boustos1" id="pone.0000798-Boustos1"></a>Boustos MD, Gay F, Diquet B (1994) In vitro test on Philippine isolates of Plasmodium falciparum against four standard antimalarials and four qinghaosu derivatives. Bull WHO  72: 729–735.  <ul class="find" data-citedArticleID="983292"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=In+vitro+test+on+Philippine+isolates+of+Plasmodium+falciparum+against+four+standard+antimalarials+and+four+qinghaosu+derivatives.&amp;auth=&amp;atitle=In+vitro+test+on+Philippine+isolates+of+Plasmodium+falciparum+against+four+standard+antimalarials+and+four+qinghaosu+derivatives." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=In+vitro+test+on+Philippine+isolates+of+Plasmodium+falciparum+against+four+standard+antimalarials+and+four+qinghaosu+derivatives." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22In+vitro+test+on+Philippine+isolates+of+Plasmodium+falciparum+against+four+standard+antimalarials+and+four+qinghaosu+derivatives.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">5.
              </span><a name="pone.0000798-Woerdenbag1" id="pone.0000798-Woerdenbag1"></a>Woerdenbag HJ, Moskal TA, Pras N, et al.  (1993) Cytotoxicity of artemisinin-related endoperoxides to Ehrlich ascites tumor cells. J Nat Prod  56: 849–856.  <ul class="find" data-citedArticleID="983368" data-doi="10.1021/np50096a007"><li><a href="http://dx.doi.org/10.1021/np50096a007" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Cytotoxicity+of+artemisinin-related+endoperoxides+to+Ehrlich+ascites+tumor+cells." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Cytotoxicity+of+artemisinin-related+endoperoxides+to+Ehrlich+ascites+tumor+cells.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">6.
              </span><a name="pone.0000798-Efferth2" id="pone.0000798-Efferth2"></a>Efferth T, Rücker G, Falkenberg M, et al.  (1996) Detection of apoptosis in KG-1a leukemic cells treated with investigational drugs. Arzneimittelforschung  46: 196–200.  <ul class="find" data-citedArticleID="983300"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Detection+of+apoptosis+in+KG-1a+leukemic+cells+treated+with+investigational+drugs.&amp;auth=&amp;atitle=Detection+of+apoptosis+in+KG-1a+leukemic+cells+treated+with+investigational+drugs." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Detection+of+apoptosis+in+KG-1a+leukemic+cells+treated+with+investigational+drugs." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Detection+of+apoptosis+in+KG-1a+leukemic+cells+treated+with+investigational+drugs.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">7.
              </span><a name="pone.0000798-Efferth3" id="pone.0000798-Efferth3"></a>Efferth T, Dunstan H, Sauerbreys A, Miyachi H, Chitambar CR (2001) The antimalarial artesunate is also active against cancer. Int J Oncol  18: 767–773.  <ul class="find" data-citedArticleID="983302" data-doi="10.3892/ijo.18.4.767"><li><a href="http://dx.doi.org/10.3892/ijo.18.4.767" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+antimalarial+artesunate+is+also+active+against+cancer." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+antimalarial+artesunate+is+also+active+against+cancer.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">8.
              </span><a name="pone.0000798-Efferth4" id="pone.0000798-Efferth4"></a>Efferth T, Sauerbrey A, Olbrich A, et al.  (2003) Molecular modes of action of artesunate in tumor cell lines. Mol Pharmacol  64: 382–394.  <ul class="find" data-citedArticleID="983304" data-doi="10.1124/mol.64.2.382"><li><a href="http://dx.doi.org/10.1124/mol.64.2.382" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Molecular+modes+of+action+of+artesunate+in+tumor+cell+lines." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Molecular+modes+of+action+of+artesunate+in+tumor+cell+lines.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">9.
              </span><a name="pone.0000798-Singh1" id="pone.0000798-Singh1"></a>Singh NP, Lai H (2001) Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells. Life Sci  70: 49–56.  <ul class="find" data-citedArticleID="983348" data-doi="10.1016/s0024-3205(01)01372-8"><li><a href="http://dx.doi.org/10.1016/s0024-3205(01)01372-8" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Selective+toxicity+of+dihydroartemisinin+and+holotransferrin+toward+human+breast+cancer+cells." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Selective+toxicity+of+dihydroartemisinin+and+holotransferrin+toward+human+breast+cancer+cells.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">10.
              </span><a name="pone.0000798-Robert1" id="pone.0000798-Robert1"></a>Robert A, Dechy-Cabaret O, Cazelles J, Meunier B (2002) From mechanistic studies on artemisinin derivatives to new modular antimalarial drugs. Acc Chem Res  35: 167–174.  <ul class="find" data-citedArticleID="983336" data-doi="10.1021/ar990164o"><li><a href="http://dx.doi.org/10.1021/ar990164o" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=From+mechanistic+studies+on+artemisinin+derivatives+to+new+modular+antimalarial+drugs." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22From+mechanistic+studies+on+artemisinin+derivatives+to+new+modular+antimalarial+drugs.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">11.
              </span><a name="pone.0000798-Zhang1" id="pone.0000798-Zhang1"></a>Zhang F, Gosser DK, Meshnick SR (1992) Hemin-catalyzed decomposition of artemisinin. Biochem Pharmacol  43: 1805–1809.  <ul class="find" data-citedArticleID="983374" data-doi="10.1016/0006-2952(92)90713-s"><li><a href="http://dx.doi.org/10.1016/0006-2952(92)90713-s" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Hemin-catalyzed+decomposition+of+artemisinin." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Hemin-catalyzed+decomposition+of+artemisinin.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">12.
              </span><a name="pone.0000798-Posner1" id="pone.0000798-Posner1"></a>Posner GH, Cumming JN, Ployprodith P, Oh CH (1995) Evidence for Fe(IV) = O in the molecular mechanism of action of the trioxane antimalarial artemisinin. J Am Chem Soc  117: 5885–5886.  <ul class="find" data-citedArticleID="983332" data-doi="10.1021/ja00126a042"><li><a href="http://dx.doi.org/10.1021/ja00126a042" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Evidence+for+Fe%28IV%29%26%23x200a%3B%3D%26%23x200a%3BO+in+the+molecular+mechanism+of+action+of+the+trioxane+antimalarial+artemisinin." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Evidence+for+Fe%28IV%29%26%23x200a%3B%3D%26%23x200a%3BO+in+the+molecular+mechanism+of+action+of+the+trioxane+antimalarial+artemisinin.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">13.
              </span><a name="pone.0000798-Posner2" id="pone.0000798-Posner2"></a>Posner GH, Cumming JN, Krasavin M (2000) Carbon-centered radicals and rational design of new antimalarial peroxide drugs. New York: Biomedical Chemistry. pp. 289–309.  <ul class="find-nolinks"></ul></li><li><span class="label">14.
              </span><a name="pone.0000798-Shterman1" id="pone.0000798-Shterman1"></a>Shterman N, Kupfer B, Moroz C (1991) Comparison of transferrin receptors, iron content and isoferritin profile in normal and malignant human breast cell lines. Pathobiology  59: 19–25.  <ul class="find" data-citedArticleID="983346" data-doi="10.1159/000163611"><li><a href="http://dx.doi.org/10.1159/000163611" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Comparison+of+transferrin+receptors%2C+iron+content+and+isoferritin+profile+in+normal+and+malignant+human+breast+cell+lines." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Comparison+of+transferrin+receptors%2C+iron+content+and+isoferritin+profile+in+normal+and+malignant+human+breast+cell+lines.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">15.
              </span><a name="pone.0000798-Moore1" id="pone.0000798-Moore1"></a>Moore J, Lai H, Li JR, Ren RL, Mc Dougall JA, Singh NP, Chou DK (1995) Oral administration of dihydroartemisinin and ferrous sulfate retarded implanted fibrosarcoma growth in the rat. Cancer Lett  98: 83–87.  <ul class="find" data-citedArticleID="983328" data-doi="10.1016/s0304-3835(06)80014-5"><li><a href="http://dx.doi.org/10.1016/s0304-3835(06)80014-5" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Oral+administration+of+dihydroartemisinin+and+ferrous+sulfate+retarded+implanted+fibrosarcoma+growth+in+the+rat." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Oral+administration+of+dihydroartemisinin+and+ferrous+sulfate+retarded+implanted+fibrosarcoma+growth+in+the+rat.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">16.
              </span><a name="pone.0000798-Efferth5" id="pone.0000798-Efferth5"></a>Efferth T, Benakis A, Romero MR, et al.  (2004) Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron. Free Radic Biol Med  37: 998–1009.  <ul class="find" data-citedArticleID="983306" data-doi="10.1016/j.freeradbiomed.2004.06.023"><li><a href="http://dx.doi.org/10.1016/j.freeradbiomed.2004.06.023" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Enhancement+of+cytotoxicity+of+artemisinins+toward+cancer+cells+by+ferrous+iron." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Enhancement+of+cytotoxicity+of+artemisinins+toward+cancer+cells+by+ferrous+iron.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">17.
              </span><a name="pone.0000798-Meshnick1" id="pone.0000798-Meshnick1"></a>Meshnick SR (1998) Artemisinin antimalarials: mechanisms of action and resistance. Med Trop (Mars) 58(Suppl)13–17.  <ul class="find" data-citedArticleID="983326"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Artemisinin+antimalarials%3A+mechanisms+of+action+and+resistance.&amp;auth=&amp;atitle=Artemisinin+antimalarials%3A+mechanisms+of+action+and+resistance." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Artemisinin+antimalarials%3A+mechanisms+of+action+and+resistance." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Artemisinin+antimalarials%3A+mechanisms+of+action+and+resistance.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">18.
              </span><a name="pone.0000798-Daniels1" id="pone.0000798-Daniels1"></a>Daniels TR, Delgado T, Rodriguez JA, Helguera G, Penichet ML (2006) The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer. Clin Immunol  121: 144–158.  <ul class="find" data-citedArticleID="983294" data-doi="10.1016/j.clim.2006.06.010"><li><a href="http://dx.doi.org/10.1016/j.clim.2006.06.010" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+transferrin+receptor+part+I%3A+Biology+and+targeting+with+cytotoxic+antibodies+for+the+treatment+of+cancer." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+transferrin+receptor+part+I%3A+Biology+and+targeting+with+cytotoxic+antibodies+for+the+treatment+of+cancer.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">19.
              </span><a name="pone.0000798-Whitney1" id="pone.0000798-Whitney1"></a>Whitney JF, Clark JM, Griffin TW, Gautam S, Leslie KO (1995) Transferrin receptor expression in nonsmall cell lung cancer. Histopathologic and clinical correlates. Cancer  76: 20–25.  <ul class="find" data-citedArticleID="983364" data-doi="10.1002/1097-0142(19950701)76:1<20::aid-cncr2820760104&gt;3.0.co;2-3"><li><a href="http://dx.doi.org/10.1002/1097-0142(19950701)76:1<20::aid-cncr2820760104&gt;3.0.co;2-3" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Transferrin+receptor+expression+in+nonsmall+cell+lung+cancer.+Histopathologic+and+clinical+correlates." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Transferrin+receptor+expression+in+nonsmall+cell+lung+cancer.+Histopathologic+and+clinical+correlates.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">20.
              </span><a name="pone.0000798-Yang1" id="pone.0000798-Yang1"></a>Yang DC, Wang F, Elliott RL, Head JF (2001) Expression of transferrin receptor and ferritin H-chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer. Anticancer Res  21: 541–549.  <ul class="find" data-citedArticleID="983370"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Expression+of+transferrin+receptor+and+ferritin+H-chain+mRNA+are+associated+with+clinical+and+histopathological+prognostic+indicators+in+breast+cancer.&amp;auth=&amp;atitle=Expression+of+transferrin+receptor+and+ferritin+H-chain+mRNA+are+associated+with+clinical+and+histopathological+prognostic+indicators+in+breast+cancer." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Expression+of+transferrin+receptor+and+ferritin+H-chain+mRNA+are+associated+with+clinical+and+histopathological+prognostic+indicators+in+breast+cancer." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Expression+of+transferrin+receptor+and+ferritin+H-chain+mRNA+are+associated+with+clinical+and+histopathological+prognostic+indicators+in+breast+cancer.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">21.
              </span><a name="pone.0000798-Ucar1" id="pone.0000798-Ucar1"></a>Ucar T, Gurer I (2003) Prognostic importance of transferrin receptor expression and correlation with K1-67 labelling indices in intracranial meningiomas. Br J Neurosurg  17: 525–529.  <ul class="find" data-citedArticleID="983360" data-doi="10.1080/02688690310001627759"><li><a href="http://dx.doi.org/10.1080/02688690310001627759" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Prognostic+importance+of+transferrin+receptor+expression+and+correlation+with+K1-67+labelling+indices+in+intracranial+meningiomas." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Prognostic+importance+of+transferrin+receptor+expression+and+correlation+with+K1-67+labelling+indices+in+intracranial+meningiomas.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">22.
              </span><a name="pone.0000798-Krishnamurthy1" id="pone.0000798-Krishnamurthy1"></a>Krishnamurthy P, Xie T, Schuetz JD (2007) The role of transporters in cellular heme and porphyrin homeostasis. Pharmacol Ther  114: 345–358.  <ul class="find" data-citedArticleID="983324" data-doi="10.1016/j.pharmthera.2007.02.001"><li><a href="http://dx.doi.org/10.1016/j.pharmthera.2007.02.001" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+role+of+transporters+in+cellular+heme+and+porphyrin+homeostasis." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+role+of+transporters+in+cellular+heme+and+porphyrin+homeostasis.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">23.
              </span><a name="pone.0000798-Higgins1" id="pone.0000798-Higgins1"></a>Higgins CF (2007) Multiple molecular mechanisms for multidrug resistance transporters. Nature  446: 749–757.  <ul class="find" data-citedArticleID="983320" data-doi="10.1038/nature05630"><li><a href="http://dx.doi.org/10.1038/nature05630" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Multiple+molecular+mechanisms+for+multidrug+resistance+transporters." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Multiple+molecular+mechanisms+for+multidrug+resistance+transporters.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">24.
              </span><a name="pone.0000798-Efferth6" id="pone.0000798-Efferth6"></a>Efferth T (2001) The human ATP-binding cassette transporter genes: from the bench to the bedside. Curr Mol Med  1: 45–65.  <ul class="find" data-citedArticleID="983308" data-doi="10.2174/1566524013364194"><li><a href="http://dx.doi.org/10.2174/1566524013364194" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+human+ATP-binding+cassette+transporter+genes%3A+from+the+bench+to+the+bedside." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+human+ATP-binding+cassette+transporter+genes%3A+from+the+bench+to+the+bedside.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">25.
              </span><a name="pone.0000798-Gillet1" id="pone.0000798-Gillet1"></a>Gillet JP, Efferth T, Remacle J (2007) Chemotherapy-induced resistance by ATP-binding cassette transporter genes. Biochem Biophys Acta – Rev Cancer  1775: 237–262.  <ul class="find" data-citedArticleID="983314" data-doi="10.1016/j.bbcan.2007.05.002"><li><a href="http://dx.doi.org/10.1016/j.bbcan.2007.05.002" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Chemotherapy-induced+resistance+by+ATP-binding+cassette+transporter+genes." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Chemotherapy-induced+resistance+by+ATP-binding+cassette+transporter+genes.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">26.
              </span><a name="pone.0000798-Gillet2" id="pone.0000798-Gillet2"></a>Gillet JP, Efferth T, Steinbach D, et al.  (2004) Microarray-based detection of multidrug resistance in human tumor cells by expression profiling of ATP-binding cassette transporter genes. Cancer Res  64: 8987–8993.  <ul class="find" data-citedArticleID="983316" data-doi="10.1158/0008-5472.can-04-1978"><li><a href="http://dx.doi.org/10.1158/0008-5472.can-04-1978" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Microarray-based+detection+of+multidrug+resistance+in+human+tumor+cells+by+expression+profiling+of+ATP-binding+cassette+transporter+genes." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Microarray-based+detection+of+multidrug+resistance+in+human+tumor+cells+by+expression+profiling+of+ATP-binding+cassette+transporter+genes.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">27.
              </span><a name="pone.0000798-Gillet3" id="pone.0000798-Gillet3"></a>Gillet JP, Schneider J, Bertholet V, de Longueville F, Remacle J, Efferth T (2006) Microarray expression profile of ABC transporters in Human Breast Cancer. Cancer Genomics Proteomics  3: 97–106.  <ul class="find" data-citedArticleID="983318"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Microarray+expression+profile+of+ABC+transporters+in+Human+Breast+Cancer.&amp;auth=&amp;atitle=Microarray+expression+profile+of+ABC+transporters+in+Human+Breast+Cancer." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Microarray+expression+profile+of+ABC+transporters+in+Human+Breast+Cancer." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Microarray+expression+profile+of+ABC+transporters+in+Human+Breast+Cancer.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">28.
              </span><a name="pone.0000798-Efferth7" id="pone.0000798-Efferth7"></a>Efferth T, Gillet JP, Sauerbrey A, Zintl F, et al.  (2006) Expression profiling of ATP-binding cassette transporters in childhood T-cell acute lymphoblastic leukemia. Mol Cancer Ther  5: 1986–1994.  <ul class="find" data-citedArticleID="983310" data-doi="10.1158/1535-7163.mct-06-0086"><li><a href="http://dx.doi.org/10.1158/1535-7163.mct-06-0086" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Expression+profiling+of+ATP-binding+cassette+transporters+in+childhood+T-cell+acute+lymphoblastic+leukemia." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Expression+profiling+of+ATP-binding+cassette+transporters+in+childhood+T-cell+acute+lymphoblastic+leukemia.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">29.
              </span><a name="pone.0000798-Steinbach1" id="pone.0000798-Steinbach1"></a>Steinbach D, Gillet JP, Sauerbrey A, et al.  (2006) ABCA3 as a possible cause of drug resistance in childhood acute myeloid leukemia. Clin Cancer Res  12: 4357–4363.  <ul class="find" data-citedArticleID="983352" data-doi="10.1158/1078-0432.ccr-05-2587"><li><a href="http://dx.doi.org/10.1158/1078-0432.ccr-05-2587" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=ABCA3+as+a+possible+cause+of+drug+resistance+in+childhood+acute+myeloid+leukemia." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22ABCA3+as+a+possible+cause+of+drug+resistance+in+childhood+acute+myeloid+leukemia.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">30.
              </span><a name="pone.0000798-Roth1" id="pone.0000798-Roth1"></a>Roth T, Burger AM, Dengler W, Willmann H, Fiebig HH (1999) Human tumor cell lines demonstrating the characteristics of patient tumors as useful models for anticancer drug screening. In: Relevance of tumor models for anticancer drug development. Fiebig HH and Burger AM (eds.) Basel, Karger, Contrib Oncol  54: 145–156.  <ul class="find" data-citedArticleID="983338"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Human+tumor+cell+lines+demonstrating+the+characteristics+of+patient+tumors+as+useful+models+for+anticancer+drug+screening.+In%3A+Relevance+of+tumor+models+for+anticancer+drug+development.&amp;auth=&amp;atitle=Human+tumor+cell+lines+demonstrating+the+characteristics+of+patient+tumors+as+useful+models+for+anticancer+drug+screening.+In%3A+Relevance+of+tumor+models+for+anticancer+drug+development." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Human+tumor+cell+lines+demonstrating+the+characteristics+of+patient+tumors+as+useful+models+for+anticancer+drug+screening.+In%3A+Relevance+of+tumor+models+for+anticancer+drug+development." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Human+tumor+cell+lines+demonstrating+the+characteristics+of+patient+tumors+as+useful+models+for+anticancer+drug+screening.+In%3A+Relevance+of+tumor+models+for+anticancer+drug+development.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">31.
              </span><a name="pone.0000798-Fiebig1" id="pone.0000798-Fiebig1"></a>Fiebig HH, Berger DP, Dengler WA, Wallbrecher E, Winterhalter BR (1992) Combined in vitro/in vivo test procedure with human tumor xenografts. In: Immunodeficient mice in oncology. Fiebig HH and Berger DP (eds.) Basel, Karger, Contrib Oncol  42: 321–351.  <ul class="find" data-citedArticleID="983312"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Combined+in+vitro%2Fin+vivo+test+procedure+with+human+tumor+xenografts.+In%3A+Immunodeficient+mice+in+oncology.&amp;auth=&amp;atitle=Combined+in+vitro%2Fin+vivo+test+procedure+with+human+tumor+xenografts.+In%3A+Immunodeficient+mice+in+oncology." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Combined+in+vitro%2Fin+vivo+test+procedure+with+human+tumor+xenografts.+In%3A+Immunodeficient+mice+in+oncology." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Combined+in+vitro%2Fin+vivo+test+procedure+with+human+tumor+xenografts.+In%3A+Immunodeficient+mice+in+oncology.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">32.
              </span><a name="pone.0000798-Alley1" id="pone.0000798-Alley1"></a>Alley MC, Scudiero DA, Monks A, et al.  (1988) Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res  48: 589–601.  <ul class="find" data-citedArticleID="983284"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Feasibility+of+drug+screening+with+panels+of+human+tumor+cell+lines+using+a+microculture+tetrazolium+assay.&amp;auth=&amp;atitle=Feasibility+of+drug+screening+with+panels+of+human+tumor+cell+lines+using+a+microculture+tetrazolium+assay." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Feasibility+of+drug+screening+with+panels+of+human+tumor+cell+lines+using+a+microculture+tetrazolium+assay." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Feasibility+of+drug+screening+with+panels+of+human+tumor+cell+lines+using+a+microculture+tetrazolium+assay.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">33.
              </span><a name="pone.0000798-Taketani1" id="pone.0000798-Taketani1"></a>Taketani S, Kakimoto K, Ueta H, Masaki R, Furukawa T (2003) Involvement of ABC7 in the biosynthesis of heme in erythroid cells: interaction of ABC7 with ferrochelatase. Blood  101: 3274–3280.  <ul class="find" data-citedArticleID="983358" data-doi="10.1182/blood-2002-04-1212"><li><a href="http://dx.doi.org/10.1182/blood-2002-04-1212" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Involvement+of+ABC7+in+the+biosynthesis+of+heme+in+erythroid+cells%3A+interaction+of+ABC7+with+ferrochelatase." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Involvement+of+ABC7+in+the+biosynthesis+of+heme+in+erythroid+cells%3A+interaction+of+ABC7+with+ferrochelatase.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">34.
              </span><a name="pone.0000798-Rubinstein1" id="pone.0000798-Rubinstein1"></a>Rubinstein LV, Shoemaker RH, Paull KD, et al.  (1990) Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines. J Natl Cancer Inst  82: 1113–1118.  <ul class="find" data-citedArticleID="983340" data-doi="10.1093/jnci/82.13.1113"><li><a href="http://dx.doi.org/10.1093/jnci/82.13.1113" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Comparison+of+in+vitro+anticancer-drug-screening+data+generated+with+a+tetrazolium+assay+versus+a+protein+assay+against+a+diverse+panel+of+human+tumor+cell+lines." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Comparison+of+in+vitro+anticancer-drug-screening+data+generated+with+a+tetrazolium+assay+versus+a+protein+assay+against+a+diverse+panel+of+human+tumor+cell+lines.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">35.
              </span><a name="pone.0000798-Dengler1" id="pone.0000798-Dengler1"></a>Dengler WA, Schulte J, Berger DP, Mertelsmann R, Fiebig HH (1995) Development of a propidium iodide fluorescence assay for proliferation and cytotoxicity assay. Anti-Cancer Drugs  6: 522–532.  <ul class="find" data-citedArticleID="983296" data-doi="10.1097/00001813-199508000-00005"><li><a href="http://dx.doi.org/10.1097/00001813-199508000-00005" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Development+of+a+propidium+iodide+fluorescence+assay+for+proliferation+and+cytotoxicity+assay." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Development+of+a+propidium+iodide+fluorescence+assay+for+proliferation+and+cytotoxicity+assay.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">36.
              </span><a name="pone.0000798-Wirth1" id="pone.0000798-Wirth1"></a>Wirth GJ, Schandelmaier K, Smith V, Burger AM, Fiebig HH (2006) Microarrays of 41 tumor cell lines for the characterization of new molecular targets: expression patterns of cathepsin B and the transferrin receptor. Oncology  71: 86–94.  <ul class="find" data-citedArticleID="983366" data-doi="10.1159/000100476"><li><a href="http://dx.doi.org/10.1159/000100476" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Microarrays+of+41+tumor+cell+lines+for+the+characterization+of+new+molecular+targets%3A+expression+patterns+of+cathepsin+B+and+the+transferrin+receptor." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Microarrays+of+41+tumor+cell+lines+for+the+characterization+of+new+molecular+targets%3A+expression+patterns+of+cathepsin+B+and+the+transferrin+receptor.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">37.
              </span><a name="pone.0000798-Steinbach2" id="pone.0000798-Steinbach2"></a>Steinbach D, Wittig S, Cario G, et al.  (2003) The multidrug resistance-associated protein 3 (MRP3) is associated with a poor outcome in childhood ALL and may account for the worse prognosis in male patients and T-cell immunophenotype. Blood  102: 4493–4498.  <ul class="find" data-citedArticleID="983354" data-doi="10.1182/blood-2002-11-3461"><li><a href="http://dx.doi.org/10.1182/blood-2002-11-3461" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+multidrug+resistance-associated+protein+3+%28MRP3%29+is+associated+with+a+poor+outcome+in+childhood+ALL+and+may+account+for+the+worse+prognosis+in+male+patients+and+T-cell+immunophenotype." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+multidrug+resistance-associated+protein+3+%28MRP3%29+is+associated+with+a+poor+outcome+in+childhood+ALL+and+may+account+for+the+worse+prognosis+in+male+patients+and+T-cell+immunophenotype.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">38.
              </span><a name="pone.0000798-Scherf1" id="pone.0000798-Scherf1"></a>Scherf U, Ross DT, Waltham M, et al.  (2000) A gene expression database for the molecular pharmacology of cancer. Nat Genet  24: 236–244.  <ul class="find" data-citedArticleID="983342" data-doi="10.1038/73439"><li><a href="http://dx.doi.org/10.1038/73439" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=A+gene+expression+database+for+the+molecular+pharmacology+of+cancer." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22A+gene+expression+database+for+the+molecular+pharmacology+of+cancer.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">39.
              </span><a name="pone.0000798-Staunton1" id="pone.0000798-Staunton1"></a>Staunton JE, Slonim DK, Coller HA, et al.  (2001) Chemosensitivity prediction by transcriptional profiling. Proc Natl Acad Sci USA  98: 10787–10792.  <ul class="find" data-citedArticleID="983350" data-doi="10.1073/pnas.191368598"><li><a href="http://dx.doi.org/10.1073/pnas.191368598" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Chemosensitivity+prediction+by+transcriptional+profiling." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Chemosensitivity+prediction+by+transcriptional+profiling.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">40.
              </span><a name="pone.0000798-Szakacs1" id="pone.0000798-Szakacs1"></a>Szakacs G, Annereau JP, Lababidi S, et al.  (2004) Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells. Cancer Cell  6: 129–137.  <ul class="find" data-citedArticleID="983356" data-doi="10.1016/j.ccr.2004.06.026"><li><a href="http://dx.doi.org/10.1016/j.ccr.2004.06.026" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Predicting+drug+sensitivity+and+resistance%3A+profiling+ABC+transporter+genes+in+cancer+cells." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Predicting+drug+sensitivity+and+resistance%3A+profiling+ABC+transporter+genes+in+cancer+cells.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">41.
              </span><a name="pone.0000798-Volm1" id="pone.0000798-Volm1"></a>Volm M, Koomägi R, Efferth T (2004) Prediction of drug sensitivity and resistance of cancer by protein expression profiling. Cancer Genomics Proteomics  1: 157–166.  <ul class="find" data-citedArticleID="983362"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Prediction+of+drug+sensitivity+and+resistance+of+cancer+by+protein+expression+profiling.&amp;auth=&amp;atitle=Prediction+of+drug+sensitivity+and+resistance+of+cancer+by+protein+expression+profiling." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Prediction+of+drug+sensitivity+and+resistance+of+cancer+by+protein+expression+profiling." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Prediction+of+drug+sensitivity+and+resistance+of+cancer+by+protein+expression+profiling.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">42.
              </span><a name="pone.0000798-Berger1" id="pone.0000798-Berger1"></a>Berger TG, Dieckmann D, Efferth T, et al.  (2005) Artesunate in the treatment of metastatic uveal melanoma – first experiences. Oncol Rep  14: 1599–1603.  <ul class="find" data-citedArticleID="983288" data-doi="10.3892/or.14.6.1599"><li><a href="http://dx.doi.org/10.3892/or.14.6.1599" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Artesunate+in+the+treatment+of+metastatic+uveal+melanoma+%26%23x2013%3B+first+experiences." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Artesunate+in+the+treatment+of+metastatic+uveal+melanoma+%26%23x2013%3B+first+experiences.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">43.
              </span><a name="pone.0000798-Shirihai1" id="pone.0000798-Shirihai1"></a>Shirihai OS, Gregory T, Yu C, et al.  (2000) ABC-me: a novel mitochondrial transporter induced by GATA-1 during erythroid differentiation. EMBO J  19: 2492–2502.  <ul class="find" data-citedArticleID="983344" data-doi="10.1093/emboj/19.11.2492"><li><a href="http://dx.doi.org/10.1093/emboj/19.11.2492" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=ABC-me%3A+a+novel+mitochondrial+transporter+induced+by+GATA-1+during+erythroid+differentiation." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22ABC-me%3A+a+novel+mitochondrial+transporter+induced+by+GATA-1+during+erythroid+differentiation.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">44.
              </span><a name="pone.0000798-Boonstra1" id="pone.0000798-Boonstra1"></a>Boonstra R, Timmer-Bosscha H, van Echten-Arends J, et al.  (2004) Mitoxantrone resistance in a small cell lung cancer cell line is associated with ABCA2 upregulation. Br J Cancer  90: 2411–2417.  <ul class="find" data-citedArticleID="983290"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Mitoxantrone+resistance+in+a+small+cell+lung+cancer+cell+line+is+associated+with+ABCA2+upregulation.&amp;auth=&amp;atitle=Mitoxantrone+resistance+in+a+small+cell+lung+cancer+cell+line+is+associated+with+ABCA2+upregulation." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Mitoxantrone+resistance+in+a+small+cell+lung+cancer+cell+line+is+associated+with+ABCA2+upregulation." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Mitoxantrone+resistance+in+a+small+cell+lung+cancer+cell+line+is+associated+with+ABCA2+upregulation.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">45.
              </span><a name="pone.0000798-Yasui1" id="pone.0000798-Yasui1"></a>Yasui K, Mihara S, Zhao C, et al.  (2004) Alteration in copy numbers of genes as a mechanism for acquired drug resistance. Cancer Res  64: 1403–1410.  <ul class="find" data-citedArticleID="983372" data-doi="10.1158/0008-5472.can-3263-2"><li><a href="http://dx.doi.org/10.1158/0008-5472.can-3263-2" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Alteration+in+copy+numbers+of+genes+as+a+mechanism+for+acquired+drug+resistance." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Alteration+in+copy+numbers+of+genes+as+a+mechanism+for+acquired+drug+resistance.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">46.
              </span><a name="pone.0000798-Park1" id="pone.0000798-Park1"></a>Park S, Shimizu C, Shimoyama T, et al.  (2006) Gene expression profiling of ATP-binding cassette (ABC) transporters as a predictor of the pathologic response to neoadjuvant chemotherapy in breast cancer patients. Breast Cancer Res Treat  99: 9–17.  <ul class="find" data-citedArticleID="983330" data-doi="10.1007/s10549-006-9175-2"><li><a href="http://dx.doi.org/10.1007/s10549-006-9175-2" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Gene+expression+profiling+of+ATP-binding+cassette+%28ABC%29+transporters+as+a+predictor+of+the+pathologic+response+to+neoadjuvant+chemotherapy+in+breast+cancer+patients." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Gene+expression+profiling+of+ATP-binding+cassette+%28ABC%29+transporters+as+a+predictor+of+the+pathologic+response+to+neoadjuvant+chemotherapy+in+breast+cancer+patients.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li></ol></div>

  </div>

      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000798.XML" value="92610"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000798.PDF" value="200314"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000798.t001.PNG_L" value="277971"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000798.t001.PNG_M" value="149270"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000798.t001.PNG_S" value="17013"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000798.t001.TIF" value="1383650"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000798.t001.PNG_I" value="45432"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000798.t002.PNG_L" value="35080"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000798.t002.PNG_M" value="45012"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000798.t002.PNG_S" value="9904"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000798.t002.TIF" value="161920"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000798.t002.PNG_I" value="15490"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000798.t003.PNG_L" value="72426"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000798.t003.PNG_M" value="97331"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000798.t003.PNG_S" value="14333"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000798.t003.TIF" value="327484"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000798.t003.PNG_I" value="33124"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000798.g001.PNG_L" value="282315"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000798.g001.PNG_M" value="26020"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000798.g001.PNG_S" value="6876"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000798.g001.TIF" value="412020"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000798.g001.PNG_I" value="22330"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000798.g002.PNG_L" value="142885"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000798.g002.PNG_M" value="34191"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000798.g002.PNG_S" value="9521"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000798.g002.TIF" value="186510"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000798.g002.PNG_I" value="43848"/>

</div>
<div class="sidebar">

  <div class="article-actions cf">
      <div class="download">
        <span class="btn"><a href="/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0000798&amp;representation=PDF" title="Download" target="_blank">Download PDF</a></span>
      </div>
      <div class="btn-reveal dropdown">
        <div class="dropdown-icon">
          <span class="btn">&nbsp;</span>
        </div>

        <div class="content">
          <ul class="bullet">
            <li><a href="/article/citationList.action?articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0000798" title="Download citations">Citation</a></li>
            <li><a href="/article/fetchObjectAttachment.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0000798&amp;representation=XML" title="Download article XML">XML</a></li>
          </ul>
        </div>
      </div> <!-- end btn-reveal dropdown-->


    <div class="btn-reveal flt-l">
        <span class="btn">Print</span>
        <div class="content">
            <ul class="bullet">
                <li id="print-article"><a href="#" onclick="if(typeof(_gaq) != 'undefined'){ _gaq.push(['_trackEvent','Article', 'Print', 'Click']); } window.print(); return false;" title="Print Article">Print article</a></li>
                <li>
                  <a href="https://www.odysseypress.com/onlinehost/reprint_order.php?type=A&page=0&journal=7&doi=10.1371/journal.pone.0000798&volume=&issue=&title=Role of Transferrin Receptor and the ABC Transporters ABCB6 and ABCB7 for Resistance and Differentiation of Tumor Cells towards Artesunate&author_name=Gerhard%20Kelter%2C%20Daniel%20Steinbach%2C%20Venkata%20Badireenath%20Konkimalla%2C%20Tsuyoshi%20Tahara%2C%20Shigeru%20Taketani%2C%20Heinz-Herbert%20Fiebig%2C%20Thomas%20Efferth&start_page=1&end_page=7" title="Odyssey Press">EzReprint</a>
                </li>
            </ul>
        </div>
    </div>

    <div class="btn-reveal flt-r">
        <span class="btn">Share</span>
        <div class="content">
            <ul class="social">
                <li><a href="http://www.reddit.com/submit?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000798" target="_blank" title="Submit to Reddit"><img src="/images/icon.reddit.16.png" width="16" height="16" alt="Reddit">Reddit</a></li>

                <li><a href="https://plus.google.com/share?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000798" target="_blank" title="Share on Google+"><img src="/images/icon.gplus.16.png" width="16" height="16" alt="Google+">Google+</a></li>

                <li><a href="http://www.stumbleupon.com/submit?url=http%3A%2F%2Fwww.plosone.org%2Farticle%2Finfo%253Adoi%252F10.1371%252Fjournal.pone.0000798" target="_blank" title="Add to StumbleUpon"><img src="/images/icon.stumble.16.png" width="16" height="16" alt="StumbleUpon">StumbleUpon</a></li>

                <li><a href="http://www.facebook.com/share.php?u=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000798&amp;t=Role%20of%20Transferrin%20Receptor%20and%20the%20ABC%20Transporters%20ABCB6%20and%20ABCB7%20for%20Resistance%20and%20Differentiation%20of%20Tumor%20Cells%20towards%20Artesunate" target="_blank" title="Share on Facebook"><img src="/images/icon.fb.16.png" width="16" height="16" alt="Facebook">Facebook</a></li>

                <li><a href="http://www.linkedin.com/shareArticle?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000798&title=Role%20of%20Transferrin%20Receptor%20and%20the%20ABC%20Transporters%20ABCB6%20and%20ABCB7%20for%20Resistance%20and%20Differentiation%20of%20Tumor%20Cells%20towards%20Artesunate&summary=Checkout%20this%20article%20I%20found%20at%20PLOS" target="_blank" title="Add to LinkedIn"><img src="/images/icon.linkedin.16.png" width="16" height="16" alt="Mendeley">LinkedIn</a></li>

                <li><a href="http://www.citeulike.org/posturl?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000798&amp;title=Role%20of%20Transferrin%20Receptor%20and%20the%20ABC%20Transporters%20ABCB6%20and%20ABCB7%20for%20Resistance%20and%20Differentiation%20of%20Tumor%20Cells%20towards%20Artesunate" target="_blank" title="Add to CiteULike"><img src="/images/icon.cul.16.png" width="16" height="16" alt="CiteULike">CiteULike</a></li>

                <li><a href="http://www.mendeley.com/import/?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000798" target="_blank" title="Add to Mendeley"><img src="/images/icon.mendeley.16.png" width="16" height="16" alt="Mendeley">Mendeley</a></li>

                <li><a href="https://www.pubchase.com/library?add_aid=10.1371%2Fjournal.pone.0000798&amp;source=plos" target="_blank" title="Add to PubChase"><img src="/images/icon.pc.16.png" width="16" height="16" alt="PubChase">PubChase</a></li>


                <script type="text/javascript">
                    // replace tweet with one that's pre-shortened to 140 chars
                    function truncateTweetText() {
                        var twtTitle = 'Role of Transferrin Receptor and the ABC Transporters ABCB6 and ABCB7 for Resistance and Differentiation of Tumor Cells towards Artesunate';
                        var twtUrl = 'http://dx.plos.org/10.1371/journal.pone.0000798';
                        // all URLs posted to twitter get auto-shortened to 20 chars.
                        var maxLength = 140 - (20 + 1);
                        // truncate the title to include space for twtTag and ellipsis (here, 10 = tag length + space + ellipsis)
                        if (twtTitle.length > maxLength) { twtTitle = twtTitle.substr(0, (maxLength - 10)) + '...'; }
                        // set the href to use the shortened tweet
                        $('#twitter-share-link').prop('href', 'http://twitter.com/intent/tweet?text=' + encodeURIComponent('#PLOSONE: ' + twtTitle + ' ' + twtUrl));
                    }
                </script>
                <li><a href="http://twitter.com/intent/tweet?text=#PLOSONE%3A%20Role%20of%20Transferrin%20Receptor%20and%20the%20ABC%20Transporters%20ABCB6%20and%20ABCB7%20for%20Resistance%20and%20Differentiation%20of%20Tumor%20Cells%20towards%20Artesunate http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000798" onclick="truncateTweetText();" target="_blank" title="Share on Twitter" id="twitter-share-link"><img src="/images/icon.twtr.16.png" width="16" height="16" alt="Twitter">Twitter</a></li>

                <li><a href="/article/email/info%3Adoi%2F10.1371%2Fjournal.pone.0000798" title="Email this article"><img src="/images/icon.email.16.png" width="16" height="16" alt="Email">Email</a></li>
            </ul>
        </div>
    </div><!--end btn-reveal flt-r-->
</div><!-- end article-actions-->

<!-- begin Crossmark -->

<a id="open-crossmark" href="#" style="margin-top: -28px; display:block"><img style="border: 0; display: none;
 padding: 10px 0 18px 0;"  id="crossmark-icon" src="/images/logo-crossmark-bw.png" /></a>
<div id="crossmark-dialog" style="display: none;" title="">
    <!-- the external CrossMark data is loaded inside this iframe -->
    <iframe id="crossmark-dialog-frame" frameborder="0"></iframe>
</div>

<!-- end crossmark -->


<div class="block" id="subject-area-sidebar-block">
    <div class="header">
        <h3>Subject Areas</h3><div title="More information" id="subject-area-sidebar-block-help-icon"><img align="right"
                                                                                                           alt="info" src="/images/button_info.png"/><div id="subject-area-sidebar-block-help"><img align="right"
                                                                                                                                                                                                    src="/images/button_info.png"/><p>
        <b>We want your feedback.</b> Do these subject areas make sense for this article? If not, click the flag
        next to the incorrect subject area and we will review it. Thanks for your help!
    </p></div></div>
    </div>


    <ul id="subject-area-sidebar-list">











          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Antisense+oligonucleotides%22" title="Search for articles in the subject area:'Antisense oligonucleotides'"><div class="flagText">Antisense oligonucleotides</div></a>
              <div data-categoryid="27433" data-articleid="24434"
                   data-categoryname="Antisense oligonucleotides"
                   class="flagImage" title="Flag 'Antisense oligonucleotides' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Cancer+treatment%22" title="Search for articles in the subject area:'Cancer treatment'"><div class="flagText">Cancer treatment</div></a>
              <div data-categoryid="20025" data-articleid="24434"
                   data-categoryname="Cancer treatment"
                   class="flagImage" title="Flag 'Cancer treatment' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Cell+differentiation%22" title="Search for articles in the subject area:'Cell differentiation'"><div class="flagText">Cell differentiation</div></a>
              <div data-categoryid="17923" data-articleid="24434"
                   data-categoryname="Cell differentiation"
                   class="flagImage" title="Flag 'Cell differentiation' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Differentiated+tumors%22" title="Search for articles in the subject area:'Differentiated tumors'"><div class="flagText">Differentiated tumors</div></a>
              <div data-categoryid="22921" data-articleid="24434"
                   data-categoryname="Differentiated tumors"
                   class="flagImage" title="Flag 'Differentiated tumors' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Glycine%22" title="Search for articles in the subject area:'Glycine'"><div class="flagText">Glycine</div></a>
              <div data-categoryid="40841" data-articleid="24434"
                   data-categoryname="Glycine"
                   class="flagImage" title="Flag 'Glycine' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Heme%22" title="Search for articles in the subject area:'Heme'"><div class="flagText">Heme</div></a>
              <div data-categoryid="21785" data-articleid="24434"
                   data-categoryname="Heme"
                   class="flagImage" title="Flag 'Heme' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Homeostasis%22" title="Search for articles in the subject area:'Homeostasis'"><div class="flagText">Homeostasis</div></a>
              <div data-categoryid="47391" data-articleid="24434"
                   data-categoryname="Homeostasis"
                   class="flagImage" title="Flag 'Homeostasis' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Sulfates%22" title="Search for articles in the subject area:'Sulfates'"><div class="flagText">Sulfates</div></a>
              <div data-categoryid="20973" data-articleid="24434"
                   data-categoryname="Sulfates"
                   class="flagImage" title="Flag 'Sulfates' as inappropriate"></div>
          </li>
    </ul>
</div>

<div class="ad">
    <div class="title">Advertisement</div>






  <iframe id='a0852f54' name='a0852f54'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=381&amp;cb=617'
    frameborder='0' scrolling='no' width='160' height='600'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a0852f54&amp;cb=9844'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=381&amp;cb=3162&amp;n=a0852f54'
      border='0' alt=''/>
    </a>
  </iframe>



</div>

<div id="twitter-alm-timeline" class="twitter-alm-timeline"></div>

<div class="block sidebar-comments">
    <div class="header">
        <h3>Comments</h3>
    </div>
      <p><a href="/annotation/listThread.action?root=4571">Referee Comments: Referee 1</a><br>Posted by PLoS_ONE_Group</p>
</div>

</div><!-- sidebar -->
    </div>
  </div>
</div>
<script src="http://wl.figshare.com/static/p_widget.js" type="text/javascript"></script><div id="pageftr">
  <div class="ftr-cols cf">
    <div class="col col-1">
      <img src="/images/logo-plos-footer.png" alt="PLOS Logo" class="logo" />
      <p><a href="/static/releaseNotes">Ambra 2.9.16</a> Managed Colocation provided <br />by <a href="http://www.isc.org/">Internet Systems Consortium</a>.<p>
      <div class="nav nav-aux">
        <a href="/static/privacy">Privacy Policy</a> |
        <a href="/static/terms">Terms of Use</a> |
        <a href="http://www.plos.org/advertise/">Advertise</a> |
        <a href="http://www.plos.org/about/media-inquiries/">Media Inquiries</a>
      </div>
    </div>
    <div class="col col-2">
      <p><a href="http://www.plos.org/publications/journals/">Publications</a></p>
      <div class="nav">
        <ul>
          <li><a href="http://www.plosbiology.org">PLOS Biology</a></li>
          <li><a href="http://www.plosmedicine.org">PLOS Medicine</a></li>
          <li><a href="http://www.ploscompbiol.org">PLOS Computational Biology</a></li>
          <li><a href="http://currents.plos.org">PLOS Currents</a></li>
          <li><a href="http://www.plosgenetics.org">PLOS Genetics</a></li>
          <li><a href="http://www.plospathogens.org">PLOS Pathogens</a></li>
          <li><a href="http://www.plosone.org">PLOS ONE</a></li>
          <li><a href="http://www.plosntds.org">PLOS Neglected Tropical Diseases</a></li>
        </ul>
      </div>
    </div>
    <div class="col col-3">
      <div class="nav">
        <p><a href="http://www.plos.org">plos.org</a></p>
        <p><a href="http://blogs.plos.org">Blogs</a></p>
        <p><a href="http://www.ploscollections.org">Collections</a></p>
        <p><a href="/feedback/new">Send us feedback</a></p>

        <p>California (US) corporation #C2354500, based in San Francisco</p>
      </div>
    </div>
  </div>
</div><!-- pageftr -->

</div><!-- end page-wrap, this div is in header.ftl -->
<script type="text/javascript" src="/javascript/jquery-1.8.1-min.js?v=Tm7VCOzZz3lE03ghpkS6SWkHbyI"></script>
<script type="text/javascript" src="/javascript/ga-min.js?v=lNQ4gt8QcPDatjsdOFl_FGpPhLY"></script>
<script type="text/javascript" src="/javascript/jquery.hoverIntent-min.js?v=mRiGNYY9cIXxVb8u0K_MdW7hHnc"></script>
<script type="text/javascript" src="/javascript/jquery.placeholder-min.js?v=21Pn56Ur9h1N4K4VZDa0nqI3Pxo"></script>
<script type="text/javascript" src="/javascript/jquery.jsonp-2.4.0-min.js?v=lqTpzoHfSq3I5Ygo01qq5WankEo"></script>
<script type="text/javascript" src="/javascript/jquery-ui-1.9.2.custom-min.js?v=raSSlfNO0YsV5uUpAKmTB9n5VTc"></script>
<script type="text/javascript" src="/javascript/jquery.tooltip-min.js?v=cw+6Smh+mdryIA25xvqIvHMrnZM"></script>
<script type="text/javascript" src="/javascript/jquery.uniform-min.js?v=kYUAnX6W2W_2fK3RIuQ2m_YFG9U"></script>
<script type="text/javascript" src="/javascript/jquery.pjax-min.js?v=939kLBjL5_YKbx71T1RHjYaD4l8"></script>
<script type="text/javascript" src="/javascript/imagesloaded-min.js?v=XeuAp8Gc3mvQUo+wZCSF8ttPwvw"></script>
<script type="text/javascript" src="/javascript/figviewer-min.js?v=yPUa0sUQ_iHkI+IRv2i9bjyZJFo"></script>
<script type="text/javascript" src="/javascript/global-min.js?v=0Q3PwjeaWtXYDnqIsQvnL_ou0qs"></script>
<script type="text/javascript" src="/javascript/jquery.touchswipe-min.js?v=huaek_e6HqTduvCNAN91dJolTyw"></script>
<script type="text/javascript" src="/javascript/jquery.base64-min.js?v=VwV1zeVqKZj5FCAdlK0q5NRxbBg"></script>
<script type="text/javascript" src="/javascript/alm-min.js?v=Y5gm6B0b4Kx2YHNObNrgEeBgXlY"></script>
<script type="text/javascript" src="/javascript/taxonomy-browser-min.js?v=vBVMuDMYkGJCXIUxLe35GoyiJNw"></script>
<script type="text/javascript" src="/javascript/jquery.filterize-min.js?v=j0ZKVnHyk2nhFy8eIuNJkp7xaM0"></script>
<script type="text/javascript" src="/javascript/plosone-min.js?v=TK4H4arL_XBSwwJq+K1N3kqYfAI"></script>
<script type="text/javascript" src="/javascript/twitter-min.js?v=xKgcxLsQFXy+at1ao1NVke8nFlM"></script>
<script type="text/javascript" src="/javascript/crossmark.1.4-min.js?v=3FO4k0SjwTaGNnKGNSqthar1080"></script>
<script type="text/javascript">
  var _sf_async_config={uid:16579,domain:"plosone.org"};
  (function(){
    function loadChartbeat() {
      window._sf_endpt=(new Date()).getTime();
      var e = document.createElement('script');
      e.setAttribute('language', 'javascript');
      e.setAttribute('type', 'text/javascript');
      e.setAttribute('src',
          (("https:" == document.location.protocol) ? "https://a248.e.akamai.net/chartbeat.download.akamai.com/102508/" : "http://static.chartbeat.com/") +
              "js/chartbeat.js");
      document.body.appendChild(e);
    }
    var oldonload = window.onload;
    window.onload = (typeof window.onload != 'function') ?
        loadChartbeat : function() { oldonload(); loadChartbeat(); };
  })();
</script>
<!-- <script type="application/javascript" src="http://crossmark.crossref.org/javascripts/v1.3/crossmark.min.js"></script> -->

</body>
</html>
